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Abstract 
 
Xenorhabdus bacteria are closely associated with Steinernema nematodes. This is a species-
specific association. Therefore, a specific Steinernema species is associated with a specific 
Xenorhabdus species. During the Xenorhabdus-Steinernema life cycle the nematodes infect 
insect larvae and release the bacteria into the hemocoel of the insect by defecation. The bacteria 
and nematodes produce several exoenzymes and toxins that lead to septicemia, death and 
bioconversion of the insect. This results in the proliferation of both the nematodes and bacteria. 
When nutrients are depleted, nematodes take up Xenorhabdus cells and leave the cadaver in 
search of their next prey. Xenorhabdus produces various broad-spectrum bioactive compounds 
during their life cycle to create a semi-exclusive environment for the growth of the bacteria and 
their symbionts. 
 
During this study, a molecular approach was used to identify four Xenorhabdus isolates from 
Steinernema sacchari SB10T, Steinernema jeffreyense J194T, Steinernema nguyeni F2T and 
Steinernema litchii WS9T as Xenorhabdus khoisanae SB10 and J194, Xenorhabdus bovienii 
F2 and Xenorhabdus griffiniae WS9, respectively. Steinernema phylogenetics were analyzed 
and the X. khoisanae-S. sacchari and X. griffiniae-S. litchii associations proved that 
X. khoisanae and X. griffiniae has the ability to switch between different nematode clades. 
 
Antimicrobial compounds produced by X. khoisanae SB10 were purified and analyzed by high-
performance liquid chromatography (HPLC) and liquid chromatography-mass spectrometry 
(LCMS), respectively. MS spectra and MSe fragmentation profiles revealed novel 
antimicrobial compounds with mass-to-charge ratios of 671.41 m/z, 259.17 m/z, 434.27 m/z 
and/or 341.15 m/z. Additionally, this study reports for the first time, the isolation of PAX 
peptides, xenocoumacins and xenorhabdins from X. khoisanae.   
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Opsomming 
 
Xenorhabdus bakterieë is naby geassosieer met Steinernema nematodes. Hierdie is ‘n spesie-
spesifieke assosiasie. Dit wil sê, ʼn spesifieke Steinernema spesie is geassosieer met ʼn 
spesifieke Xenorhabdus spesie. Tydens die Xenorhabdus-Steinernema lewenssiklus infekteer 
die nematodes inseklarwes en word die bakterieë in die hemoseel van die insek vrygestel deur 
middel van ontlasting. Die bakterieë en nematodes produseer verskeie ekso-ensieme en 
toksiene wat lei tot septisemie, dood en bio-omskakeling van die insek. Dit lei tot die 
vermeerdering van beide die nematodes en bakterieë. Sodra nutriente uitgeput is, neem 
nematodes Xenorhabdus selle op en verlaat die kadawer opsoek na hul volgende prooi. 
Xenorhabdus produseer verskeie breë-spektrum bioaktiewe verbindings tydens hul 
lewenssiklus om ‘n gedeeltelike eksklusiewe omgewing te skep vir die groei van die bakterieë 
en hul simbionte. 
 
Gedurende hierdie studie was ‘n molekulêre benadering gebruik om vier Xenorhabdus isolate 
vanaf Steinernema sacchari SB10T, Steinernema jeffreyense J194T, Steinernema nguyeni F2T 
en Steinernema litchii WS9T te identifiseer as, Xenorhabdus khoisanae SB10 en J194, 
Xenorhabdus bovienii F2 en Xenorhabdus griffiniae WS9, afsonderlik. Steinernema 
filogenetika was geanaliseer en die X. khoisanae-S. sacchari en X. griffiniae-S. litchii 
assosiasies het bewys dat X. khoisanae en X. griffiniae die vermoë het om te wissel tussen 
nematodes van verskillende klades.  
 
Antimikrobiese verbindings geproduseer deur die isolaat, X. khoisanae SB10, was gesuiwer en 
geanaliseer deur hoëdrukvloeistofchromatografie (HDVC) en vloeistofchromatografie massa-
spektrometrie (VCMS), afsonderlik. MS spektra en MSe fragementasie profiele het nuwe 
antimikrobiese verbindings met massa-tot-lading verhoudings van 671.41 m/z, 259.17 m/z, 
434.27 m/z en/of 341.15 m/z onthul. Vêrder rapporteer hierdie studie, vir die eerste keer, dat 
PAX peptiede, xenokoumasiene en xenorhabdiene geïsoleer was vanaf X. khoisanae.  
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Preface 
 
This thesis is represented as a compilation of 6 chapters. Chapters 1, 2, 5 and 6 are written 
according to instructions of the Journal of Applied and Environmental Microbiology. Chapters 
3 and 4 have been published in Current Microbiology (2017, volume 74:8, pp 938-942) and 
Archives of Microbiology (2017, doi: 10.1007/s00203-017-1452-4), respectively. 
 
Chapter 1: General Introduction 
Chapter 2: Phenotypic and Genotypic Characteristics of Xenorhabdus Species, Their 
Association with Entomopathogenic Nematodes and Production of Antimicrobial Compounds  
Chapter 3: Three Novel Xenorhabdus-Steinernema Associations and Evidence of Strains of 
X. khoisanae Switching Between Different Clades 
Chapter 4: First Report of a Symbiotic Relationship Between Xenorhabdus griffiniae and an 
Unknown Steinernema from South Africa 
Chapter 5: Novel Antimicrobial Compounds from Xenorhabdus khoisanae SB10, and the 
First Report of PAX peptides, Xenocoumacins and Xenorhabdins from this Species  
Chapter 6: General Discussion and Conclusions 
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General Introduction 
 
The genus Xenorhabdus consists of Gram-negative bacteria belonging to the 
Enterobacteriacaea family (1). These bacteria co-exist in a mutualistic relationship with 
pathogenic nematodes of the genus Steinernema (2), this is a species-specific association, i.e. 
a single Xenorhabdus sp. is associated with a specific Steinernema sp. (3). However, a single 
Xenorhabdus sp. associating with more than one Steinernema sp. has been reported (4–6). The 
latter, referred to as switching of hosts, is generally between nematodes in the same clade, but 
more recent studies have shown that the switching of hosts may also take place between 
nematodes of different clades (4–6).  
 
The mutualistic relationship between Steinernema spp. and Xenorhabdus spp. is critical in the 
formation of a tripartite relationship with the host (insect) larvae. Xenorhabdus bacteria are 
carried in the receptacle of Steinernema nematodes when in the infective juvenile (IJ) phase 
(7, 8). Infective juveniles position themselves near the soil surface (9), enter the host through 
natural openings such as respiratory spiracles, mouth or anus and migrate to the hemocoel to 
excrete viable cells of Xenorhabdus (10). The host’s immune response is inhibited with 
compounds produced by the nematodes and bacterial cells. Exoenzymes and toxins produced 
by Xenorhabdus lead to septicemia (11–14) and, ultimately, death of the host within 24-48 h. 
The nematodes reproduce sexually and repeat their life cycle until nutrients become depleted. 
During this phase, Xenorhabdus cells produce a number of antimicrobial compounds to create 
a semi-exclusive environment for themselves and the nematodes (10, 15). Second-phase 
juveniles stemming from the mutualistic relationship develop into IJs via the third phase. These 
IJs harbour viable Xenorhabdus cells.  
 
Xenorhabdus spp. produce various bioactive compounds throughout their life cycle. These 
bacteria are, however, an underestimated and neglected source of novel bioactive compounds. 
Biologically active compounds produced by Xenorhabdus spp. have a broad-spectrum of 
antimicrobial activity, inhibiting the growth of bacteria, fungi and protozoa, the development 
of insects and nematodes, and the formation of cancerous cells (15). The variety of bioactive 
compounds produced by Xenorhabdus spp. differ, even between strains of the same species. 
Polyketide synthetases (PKS) and non-ribosomal peptide synthetases (NRPS) are responsible 
for the production of a diverse group of peptides, e.g. depsipeptides (16–18), xenocoumacins 
(19) and PAX peptides (peptide-antimicrobial-Xenorhabdus) (20). Other Xenorhabdus 
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antimicrobial compounds include benzylideneacetone (21), indole derivatives (22) and 
bacteriocins (23, 24). 
 
The efficiency of Xenorhabdus bioactive compounds in the agricultural industry has been 
shown with various studies (25–29). Xenorhabdus bacteria, as a source of bioactive 
compounds, have exceeding potential, however, not only in the agricultural industry, but also 
in the healthcare and food industries. According to genomic analysis done on X. nematophila 
DSM 3370T (30), only a fraction of the bioactive compounds that may be produced by 
Xenorhabdus spp. have been reported. It is evident that the research already done on 
Xenorhabdus bacteria is only the prelude to what is yet to come.  
 
In the first section of this thesis, four Xenorhabdus strains (SB10, J194, WS9 and F2), isolated 
from Steinernema sacchari, Steinernema jeffreyense, Steinernema litchii and Steinernema 
nguyeni, respectively, are identified to species level. Before this study, the Xenorhabdus 
symbionts associated with these nematodes had not been reported. Identification was done by 
using biochemical tests, PCR and genome sequencing. The results led to the discovery of 
intriguing novel Xenorhabdus-Steinernema associations. 
 
The second section of the study focussed on the antimicrobial activity of Xenorhabdus strain 
SB10. Antimicrobial compounds in the cell-free extract of Xenorhabdus khoisanae SB10 was 
isolated with XAD-16 beads, purified by high-performance liquid chromatography (HPLC) 
and fractions with antimicrobial activity subjected to liquid chromatography–mass 
spectrometry (LCMS) for putative identification. Strain SB10 was selected as no previous 
studies have been done on the bioactive compounds produced by X. khoisanae. The isolation 
and purification methods for antimicrobials produced by strain SB10 was optimized. 
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Abstract 
 
The genus Xenorhabdus belongs to the family Enterobacteriaceae. These bacteria live 
mutualistically within entomopathogenic nematodes of the genus Steinernema. This 
association is species-specific, however, sharing of a specific Xenorhabdus sp. does occur 
between Steinernema hosts. During the Xenorhabdus-Steinernema life cycle, insect larvae are 
infected and killed, while both mutualists produce bioactive compounds. These compounds 
work synergistically to ensure the reproduction and proliferation of the nematodes and bacteria. 
Over the past two decades, the number of studies done on the bioactive compounds produced 
by Xenorhabdus spp. have increased drastically. These compounds are often broad-spectrum 
with activity against bacteria, fungi, insects, nematodes, protozoa and cancerous cells. It is 
evident that this genus is greatly underestimated and neglected in the search for novel bioactive 
compounds, especially when taking into consideration the need for novel antibiotics. 
 
Keywords Xenorhabdus, Steinernema, bioactive compounds 
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The Genus Xenorhabdus 
 
The genus Xenorhabdus consists of 26 species and belongs to the family Enterobacteriaceae 
(1). The rod-shaped cells (0.3-2.0 µm x 2.0-10.0 µm) stain Gram-negative, have peritrichous 
flagella when motile, do not reduce nitrate and, are oxidase and catalase negative.  No 
endospores are produced, but crystalline inclusions may form during stationary growth.  
Spheroplasts with an average diameter of 2.6 µm may form towards the end of exponential 
growth (2).  Most members of the genus are mesophilic and grow at 28 °C, although some 
strains may grow at 42 °C.  Metabolism is respiratory and fermentative and the cells are 
classified as facultative anaerobes.  Mannose, glycerol and N-acetylglucosamine are usually 
fermented.  Some species ferment fructose.  Most strains produce DNases, proteases and 
lipases. 
 
Xenorhabdus spp. live in close association with entomopathogenic nematodes of the family 
Steinernematidae.  This association directly influences the viable state of the bacterial cells.  
Two cell types, referred to as phase variants, have been described.  Cells naturally associated 
with actively reproducing nematodes are in phase I (form I, or primary form), but change to 
phase II cells during later stages of the nematode reproduction cycle, i.e. when nematodes infect 
the insect cadaver (3).  Conversion to phase II also occurs when cells are repeatedly sub-
cultured in vitro (4).  Phase I cells are larger than phase II cells, are motile, have swarming 
abilities, form crystalline inclusion bodies, and produce proteases, lipases and antimicrobial 
compounds (5–10).  Phase I cells absorb certain dyes and can be distinguished from phase II 
cells by streaking the cells onto nutrient agar supplemented with 0.025% (w/v) bromothymol 
blue and 0.004% (w/v) triphenyltetrazolium chloride (NBTA medium) (11).  Colonies on 
NBTA medium are dark blue with a red core and are surrounded by a clear zone.  Exceptions 
to the rule have been reported, i.e. on rare occasions phase I cells do not absorb bromothymol 
blue (12). 
 
Xenorhabdus spp. are differentiated based on biochemical characteristics (Table 1), but 
identification has to be confirmed using genotypic classification methods.  Sequences of genes 
encoding recombinase A (recA), DNA gyrase subunit B (gyrB), DNA polymerase III beta chain 
(dnaN), initiation factor B (infB), glutamyl-tRNA synthetase catalytic subunit (gltX) and 
16S rRNA (16S rDNA) are usually compared to determine the level of genetic relatedness. 
Furthermore, DNA-DNA hybridization of the entire genome may be used to confirm the exact 
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species.  The phylogenetic relatedness of Xenorhabdus spp., compiled from sequences in 
GenBank, is shown in Fig. 1. 
 
Association of Xenorhabdus with Entomopathogenic Nematodes 
 
Xenorhabdus spp. are closely associated with entomopathogenic nematodes (EPNs) of the 
family Steinernematidae Travassos, specifically the genus Steinernema, and they are believed 
to increase the virulence and reproduction (thus “fitness”) of the nematode (13).  Until recently, 
the general assumption was that a specific Xenorhabdus sp. can only infect one 
Steinernema species. This has clearly been demonstrated in a study conducted by 
Sicard et al. (13).  The authors have shown that the fitness of Steinernema carpocapsae 
improved when associated with Xenorhabdus nematophila, but not when associated with non-
native Xenorhabdus spp.  More recent findings have, however, shown that a single species of 
Xenorhabdus may be associated with several Steinernema spp. (Table 2).  Murfin et al. (14) 
reported an increase in the fitness of Steinernema nematodes when infected with a strain of 
Xenorhabdus bovienii native to the nematode, or when associated with a strain from another 
Steinernema sp. closely related to the original nematode.  Some authors hypothesized that the 
association of a specific Xenorhabdus sp. with more than one Steinernema sp. is an indication 
that the respective nematodes are phylogenetically related.  The findings of Lee and Stock (15) 
provided the final answer to this hypothesis.  The authors have shown that host switching of 
Xenorhabdus spp. have occurred in clades and between clades as many as 17 times.  
Steinernema beitlechemie from the Cameroonense-clade (16) is associated with 
Xenorhabdus khoisanae. However, X. khoisanae was first isolated from 
Steinernema khoisanae that belongs to the Glaseri-clade (17, 18).  In a more recent paper, 
further evidence of X. khoisanae switching between clades was reported when X. khoisanae 
was isolated from Steinernema sacchari of the Cameroonense-clade (19). 
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Table 1 Carbohydrate fermentation and assimilation by Xenorhabdus spp. 
Characteristic 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 
Acid production from:                           
5-Ketogluconate + v + - - n.a. v w + + + w + w + - - w w + v w w - n.a. + 
Aesculin + - - - v - v + + v - + - - - + + + + - v - + + - + 
Fructose + v + v v - v + + + + + + + - - - + + + v + + v - + 
gluconate + v - - - - - - - - + - - + - - - + w - - w + - - - 
Glucose + + + + v + + - + + + + - + + + + + + + + + + + - + 
Inositol - n.a. + v v - - - v + v - - w - - - + - v - w + + - - 
Maltose + v - v v + v - v - - + + + + + + + + v + + + v - + 
mannose + + + + v + + - + + + + + + + + + + + + + + + v - + 
N-acetyl-glucosamine + + v + v - v - v v + + + + - - - + + + + + + v - + 
Ribose + v - - v - v + v - + w + + - + - + + v - - + v - - 
Sorbitol - - - - - - - - - - - - - - - - - - - - - - - + - - 
trehalose + v - - v + - - n.a. - v + - v - + + + + v v + - - - + 
Assimilation of:                           
Aesculin + - v - v - v + + v v + - + - v + + + - v - + + - + 
Fructose + v + v v + v - v + + v + n.a. - - - + + + v + + - + + 
gluconate + + v - + + v + + + + + w + - v - + + v + + + + + + 
Glucose + + + + + + + + + + + - + + - + + + + + + + + + + + 
Inositol - - - - + - - w v + + - + n.a. - - - + w v - + + + - w 
Maltose + + v + + + + + + + - - + + - + + + + + + + + + + + 
mannose + + + + v + v + + + + + + + - + + + + + + + + + + + 
N-acetyl-glucosamine + + v + + + + + + + + + + + - + + + + + + + + + + + 
Ribose + v - - v + v - v - + - - n.a. - + - + + - - - + v - - 
Trehalose + + + v + + v + + v + + + n.a. - + + + + + + + - v + + 
(1) X. beddingii, (2) X. bovienii, (3) X. budapestensis, (4) X. cabanillasii, (5) X. doucetiae, (6) X. eapokensis, (7) X. ehlersii, (8) X. griffiniae, (9) X. hominickii, (10) 
X. indica, (11) X. innexi, (12) X. ishibashii, (13) X. japonica, (14) X. khoisanae, (15) X. koppenhoeferi, (16) X. kozodoii, (17) X. magdalenensis, (18) X. mauleonii, 
(19) X. miraniensis, (20) X. nematophila, (21) X. poinarii, (22) X. romanii, (23) X. stockiae, (24) X. szentirmaii, (25) X. thuongxuanensis, (26) X. vietnamensis. 
+, 90% of strains positive; -, 90% of strains negative; v, variable reaction; w, weak reaction; n.a., not available.  Data obtained from (19–21).
Stellenbosch University  https://scholar.sun.ac.za
 
 
  
 
Figure 1 Phylogenetic tree of known Xenorhabdus species, based on the protein-coding genes, 
recombinase A (recA), DNA gyrase subunit B (gyrB), DNA polymerase III beta chain (dnaN), 
initiation factor B (infB) and glutamyl-tRNA synthetase catalytic subunit (gltX). Type strains 
are indicated by the superscript letter T. Photorhabdus species are used as outgroups. Bootstrap 
values above 70% are shown. Gene sequences were obtained from the National Center for 
Biotechnology Information (NCBI) and MEGA6.0 (22) was used to construct the phylogenetic 
tree. 
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Table 2 Mutualistic relationships between Steinernema nematodes and Xenorhabdus bacteria.  
Xenorhabdus  Steinernema Source 
X. beddingii S. longicaudum (15) 
X. bovienii S. affine, S. anatoliense, S. costaricense, S. feltiae, S. 
intermedium, S. jollieti, S. kraussei, S. litorale, S. nguyeni, 
S. oregonense, S. puntauvense, S. sichaunense, S. weiseri, 
S. silvaticum 
(5, 15, 19, 23–28) 
X. budapestensis S. bicornutum, S. ceratophorum (23, 29) 
X. cabanillasii S. riobrave (23) 
X. doucetiae S. diaprepesi (23) 
X. eapokensis S. eapokense (21) 
X. ehlersii S. serratum, S. longicaudum (23, 29) 
X. griffiniae S. hermaphroditum (Previously referred to as S. dharanai) 
S. litchi, S. khoisanae (See Chapter 4 for clarity) 
(23, 30) 
X. hominickii S. karii, S. monticolum (23, 31) 
X. indica S. thermophilum, S. yirgalemense, S. abbasi (23, 32, 33) 
X. innexi S. scapterisci (29) 
X. ishibashii S. aciari (20) 
X. japonica S. kushidai (34) 
X. khoisanae S. khoisanae, S. jeffreyense, S. sacchari, S. beitlechemie (17, 19) 
X. koppenhoeferi S. scarabaei (23) 
X. kozodoii S. arenarium, S. apuliae, S. boemarei (15, 23, 26) 
X. magdalenensis S. austral (35) 
X. mauleonii Steinernema sp. (23) 
X. miraniensis Nematode from the family Steinernematidae, isolated from 
Australia 
(26) 
X. nematophila S. carpocapsae (previously referred to as S. anatoliense) S. 
websteri 
(15, 36) 
X. poinarii S. glaseri, S. cubanum (25, 37) 
X. romanii S. puertoricense (23) 
X. stockiae S. siamkayai (23) 
X. szentirmaii S. rarum, S. costaricense (15, 29) 
X. thuongxuanensis S. sangi (21) 
X. vietnamensis S. sangi (38) 
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The Xenorhabdus-Steinernema Life Cycle 
 
Cognate nematodes and bacteria may be disassociated under laboratory conditions, without 
affecting the fitness of the bacteria.  However, a decrease in reproduction rate and virulence of 
the nematode occurs after a few generations without their symbionts (13, 39).  The different 
stages in the life cycle of the symbionts are described below. 
 
Stage I. In the first stage of development, Steinernema nematodes are present in the infective 
juvenile (IJ) form, also referred to as a special third phase juvenile or dauer juvenile.  The IJs 
are encased by a double outer cuticle and have a closed mouth and anus (40).  IJs are relatively 
resistant to environmental stressors and may live for several months without feeding (41).  
Xenorhabdus bacteria are carried in a specialized organ of the IJ, called a receptacle (42).  This 
organ is a modification of the two most anterior cells of the intestine with sizes varying from 
8 x 5 µm to 46 x 17 µm (43).  IJs of the family Steinernematidae may actively search for insect 
hosts, or wait near the soil surface for passing insects  (44).  Once an insect is in close proximity, 
the nematode enters the insect through natural openings, such as the mouth, anus and respiratory 
spiracles, and migrates to the hemocoel. 
 
Stage II. Nutrients in the hemocoel of a susceptible host (not fully characterized), trigger the 
start of a new phase in the nematode’s life cycle (Fig. 2), referred to as the recovered, feeding 
phase (J3).  Recovered nematodes start feeding and moult to the fourth phase (J4).  During the 
recovery phase, the bacteria are released by defecation, as a result of ingestion of the insect 
hemolymph. The hemolymph has a sophisticated immune system that protects it from invading 
microorganisms (45).  However, Steinernema produce proteins that suppress the immune 
response (46) and the bacteria start to multiply.  Exoenzymes and toxins are released, which 
leads to septicemia and bioconversion of the insect host.  This results in death of the insect 
within 24-48 h.  The J4 phase develops into gonochoristic males and females that reproduce by 
copulation and production of eggs.  The eggs develop into adult nematodes by passing through 
juvenile phases J1 to J4.  This cycle is repeated for as long as nutrients are available (depending 
on the size of the host), generally for up to three generations.  The bacteria proliferate and 
produce various antimicrobials, including antibiotics and bacteriocins (47).  This creates a semi-
exclusive environment for the nematodes and Xenorhabdus by preventing the colonization of 
the cadaver by other soil micro-organisms. 
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Stage III. After one to three generations (depending on the size of the host insect), second phase 
juveniles (J2) develop into IJs, special third phase juveniles.  An increase in the nematode 
population depletes the nutrients and leads to the accumulation of byproducts, such as NH3 (48).  
Nematodes take bacterial cells up in their receptacle and cease feeding.  They then re-create 
their double outer cuticle layer that closes the mouth and anus.  At this stage, thousands of IJs 
leave the host cadaver in search of their next prey. 
 
 
 
Figure 2 The Steinernema life cycle. The infective juvenile (IJ) nematodes infect an insect host 
and recover to the feeding phase (J3). J3 nematodes moult into fourth phase (J4) juveniles, 
which in turn develop into male and female adults.  These adults reproduce and lay eggs.  The 
eggs hatch as first phase juveniles (J1) which feed and moult to second, third and fourth juvenile 
phases (J2-J4), and ultimately into adults.  After one to three generations, when nutrients are 
depleted, second phase juveniles develop into IJs (special third phase juveniles).  Each of the 
IJs host Xenorhabdus bacteria in their receptacle.  These IJs then leave the cadaver and await a 
new prey. 
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Synergistic Effect 
 
Xenorhabdus spp. produce several compounds that inhibit the immune system and lead to 
septicemia of the host.  Xenorhabdus nematophila produces UnA, a protein that inhibits the 
ability of hemocytes to aggregate and form capsules or nodules around the nematodes and 
bacteria (49).  Additionally, outer membrane proteins and lipopolysaccharides of 
X. nematophila reduce non-self recognition in Galleria mellonella Linnaeus 
(Lepidoptera; Phyralidae) hemocytes, which allow the bacteria to avoid adhesion to hemocytes 
(50).  This inhibits the activation of phenoloxidase, an important enzyme in the insects’ immune 
response to foreign organisms (51).  In contrast, Xenorhabdus budapestensis D43 produces a 
57 kDa insecticidal protein that activates the phenoloxidase cascade and elicits an intense 
immune response in G. mellonella larvae (52).  This leads to an excessive production of 
quinones, which are toxic to the larvae.  Xenorhabdus nematophila influences the immune 
response of insects by preventing the production of phospholipase A2 (PLA2) and inhibiting its 
activity (50, 53–55). PLA2 is partly responsible for the biosynthesis of eicosanoids.  Eicosanoids 
play a role in mediating hemocyte behavior, thereby regulating the immune response of the 
insect.  The absence of eicosanoids results in severe immune depression and septicemia of the 
insect.  Xenorhabdus nematophila, Xenorhabdus japonica, Xenorhabdus kozodoii and 
Xenorhabdus beddingii cause apoptosis of insect hemocytes (56–58).  The compound 
responsible for cytotoxicity of X. nematophila has been identified as protein CyA (cytotoxic 
activity).  From these studies, it is clear that Xenorhabdus bacteria play an important role in 
inhibiting the immune system of insects and in the production of cytotoxins, toxins and 
hemolysins killing the insect. 
 
Despite the various bioactive compounds produced by Xenorhabdus spp., few strains cause 
infection of insect larvae when taken up orally.  It is thus important for the bacteria to be 
“vectored” into the insect hemocoel by the nematodes.  Apart from spreading Xenorhabdus spp. 
amongst insect hosts, nematodes support the survival of the bacteria.  Steinernema nematodes 
produce specific proteins that inhibit  the insects’ antimicrobial compounds (46).  This promotes 
growth of their respective Xenorhabdus mutualists.  The attributes of the nematode in this 
tripartite relationship are not merely to vector and protect the bacteria, but to also contribute in 
killing of the host insect.  Axenic, therefore sterile, S. carpocapsae (59, 60) and S. feltiae (61) 
kill G. mellonella larvae.  This is likely due to insecticidal compounds produced by Steinernema 
nematodes.  Steinernema carpocapsae, and most likely also S. feltiae, produce a protein toxic 
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to G. mellonella larvae (62).  However, not all axenic Steinernema nematodes are efficient in 
killing G. mellonella larvae. 
 
Akhurst (63) reported that neither Steinernema glaseri, nor its symbiont, Xenorhabdus poinarii, 
was able to kill G. mellonella larvae when tested independently.  However, when combined, 
the symbionts killed all G. mellonella larvae.  Similar results were reported for 
Steinernema scapterisci and its Xenorhabdus symbiont (64).  Steinernema feltiae and 
X. bovienii are each virulent on their own, with a mortality rate of 39% and a virulence of LC50 = 
15 700 colony forming units, respectively, when Tipula oleracea Linneaus (Diptera; Tipulidae) 
was used as host.  The combination of both partners however, increased the virulence to a 
mortality rate of 90% (61). 
 
It is undeniable, that the nematodes, as well as their bacterial symbionts, are crucial for killing 
insect host larvae and neither are especially effecient at doing so without their symbiont.  The 
efficiency of killing host larvae cannot be attributed solely to an additive effect of the nematode 
and bacterial toxins, as virulence increases drastically when these two mutualists act together.  
This phenomenon should therefore, rather be described as a synergistic affect, as proposed by 
Boemare (65).  
 
EPNs as Biological Control Agents 
 
The early 20th century led to the discovery that EPNs could be useful in agriculture as biological 
control agents.  Since the 1980’s research on EPNs has expanded rapidly (65) and in the current 
day and age, EPNs have been very effective in the treatment of insect pests.  Since the 
combination of Steinernema nematodes and Xenorhabdus bacteria is highly effective, this 
mutualistic relationship has been exploited for biological control purposes. For example, 
Steinernema yirgalemense cause a 100% mortality of false codling moth larvae 
(Thaumatotibia leucotreta, Meyrick) when as few as 50 IJs per insect were used (66).  Other 
South African studies have shown these mutualists to be effective against codling moth 
(Cydia pomonella, L.) (67), mealy bugs (Planococcus ficus, Signoret) (68), sugarcane stalk 
borer (Eldana saccharina, Walker) (69), fruit flies Ceratitis capitate (Wiedemann) and 
Ceratitis rosa (Karsch) (70) and many more. 
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Xenorhabdus Bioactive Secondary Metabolites 
 
Most naturally produced antimicrobial metabolites are produced by bacteria (71), of which 
Streptomyces (72), Bacillus (73), cyanobacteria (74), myxobacteria (75) and Pseudomonas (76) 
are the best studied. There are, however, some immensely underestimated and neglected 
antimicrobial sources.  These include species of the bacteria Bulkholderia, Janthinobacterium, 
Lysobacter, non-pathogenic clostridia, Photorhabdus and Xenorhabdus.  Although a number 
of antimicrobial compounds are produced by these bacteria, they have not been studied to the 
same extent as the previously mentioned species (77).  Xenorhabdus bacteria are known to 
produce broad-spectrum compounds with activity against bacteria, fungi, insects, nematodes, 
protozoa and cancer cells (47).  These activities each play a unique role in the protection and 
bioconversion of the host cadaver, and promote reproduction and growth of the nematodes. 
 
Dutky (78) was the first to suggest that the symbiont of Neoaplectana (now known as 
Steinernema), could produce antimicrobial compounds.  It was only 22 years later that scientists 
started to show an interest in these compounds.  Paul et al. (79) identified several novel 
antibacterial compounds produced by Xenorhabdus spp.  Since this discovery, various 
additional Xenorhabdus compounds have been described.   
 
Various Xenorhabdus bioactive secondary metabolites are produced by polyketide synthetases 
(PKS) and/or non-ribosomal peptide synthetases (NRPSs).  The latter are catalysts that use 
intricate reactions to assemble diverse peptides without the assistance of ribosomes (80).  They 
contain a set of modules that are responsible for the stepwise incorporation of amino acids.  
These modules, in turn, contain domains that trigger complex reactions leading to production 
of the final compound.  Secondary metabolites produced by Xenorhabdus spp. include 
depsipeptides, xenocoumacins, fabclavines, pristimamycin IIa, xenortides, rhabdopeptides, 
bicornitun, PAX peptides, nemaucin, cabanillasin, dithiopyrrolone derivatives, indole-
containing compounds, unnamed peptides, benzylideneacetone, rhabduscin, bacteriocins, 
phenethylamine and trypamine derivatives, phenethylamides, chaiyaphumines and 
xenofuranones. Chemical structures are shown in Fig. 3. 
 
Depsipeptides. Depsipeptides are peptides with one or more amide group replaced by a 
hydroxy acid, leading to the formation of an ester bond.  These peptides generally contain 
alternating peptide and ester bonds.  Five classes of depsipeptides produced by 
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Xenorhabdus spp. have been characterized. The first class consists of eight 
tridecadepsipeptides, named xenoamicins (81). These compounds consist mainly of 
hydrophobic amino acids and are produced by Xenorhabdus doucetiae and 
Xenorhabdus mauleonii.  The gene cluster encoding the biosynthesis of xenoamicins was 
identified by using the whole genome of X. doucetiae DSM 17909.  The gene cluster consists 
of the five NRPSs, XabABCD and the aspartic acid decarboxylase XabE.  XabABCD contains 
13 modules for the synthesis of xenoamicins, while XabE is suggested to be involved in the 
formation of β-alanine.  The large number of hydrophobic amino acids suggested that 
xenoamicins interact with the cytoplasmic membrane.  However, no antibacterial or antifungal 
activity was recorded for xenoamicin A, which suggests a different mode of activity.  Anti-
protozoal and weak cytotoxic activities have been reported for xenoamicin A, but the target site 
has not been identified. 
 
The second depsipeptide class, isolated from Xenorhabdus indica, was characterized by 
Kronenwerth et al. (82).  These depsipeptides contain an additional fatty acid chain which is 
attached to one of the amino acids, which classifies them as lipodepsipeptides.  The peptides 
are named after their amino acid sequence, T-A-X-L-L-L-A (X = L, F or Y), and are referred 
to as taxlllaids (A-G).  Seven variants were described, each classified based on the length of the 
fatty acid chain, the third amino acid and the overall structure of the molecule, i.e. an open chain 
or ring structure.  The synthesis of taxlllaids are encoded by a gene cluster consisting of two 
NRPSs, TxlA and TxlB, containing four and three modules, respectively.  Natural taxlllaid A 
and synthetic taxlllaids B-G have antiprotozoal activity, with taxlllaid A also being cytotoxic 
to human carcinoma cells (HeLa).  
 
The third class of depsipeptides are classified as the indole-containing xenematides.  
Xenematide A was the first example, isolated from X. nematophila (83).  The molecule is cyclic, 
antibacterial and weakly insecticidal.  Three years later, Crawford et al. (84) isolated another 
three xenematides (B-D) from X. nematophila and showed that the NRPS, classified as 
XNC1_2713, is responsible for the production of xenematide A.  This was accomplished by 
knocking out the gene that encodes the XNC1_2713 NRPS in X. nematophila. Metabolite 
analysis revealed that production of xenematide A was terminated in the mutant strain. 
Xenematides are not restricted to X. nematophila or the genus Xenorhabdus, as protein 
homologs have been identified in X. bovienii and Photorhabdus asymbiotica.  
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The final two depsipeptide classes consist of xenobactin and szentiamide (90, 91).  Xenobactin 
was isolated from the unknown Xenorhabdus sp. strain PB30.3 and szentiamide from 
Xenorhabdus szentirmaii.  Both compounds have good activity against the causative agent of 
malaria, Plasmodium falciparum and some activity against Trypanosoma brucei rhodesiense 
and Trypanosoma cruzi.  Szentiamide does not have any effect on the growth of bacteria or 
yeasts, however, it has an additional weak cytotoxicity against G. mellonella hemocytes.  
Contrary to szentiamide, xenobactin has no cytotoxic activity, but is active against 
Micrococcus luteus.  The antibacterial activity is likely due to the hydrophobic nature of the 
peptide and the compound is proposed to interact with the membrane of M. luteus.  
 
Xenocoumacins. These peptides, first described by McInerney (92), have benzopyran 
structures and are some of the major antimicrobials produced by X. nematophila.  Xcn1 is active 
against Gram-positive and Gram-negative bacteria, and has antifungal and antiulcer activity.  
Xcn2 has less antibacterial activity and no antifungal activity, but has antiulcer activity. More 
recently, Reimer (93) discovered that Xcn2 is produced from Xcn1 through reactions encoded 
by genes xcnM and xcnN.  In a study conducted by Park et al. (94), the xcnM gene was 
inactivated, which led to an increased Xcn1 level, as expected, but it also decreased cell viability 
by 20-fold.  The conversion of Xcn1 to Xcn2 was therefore, suggested to be a mechanism used 
by the bacteria to avoid self-toxicity.  Xcn1 is proposed to be the terminal PKS/NRPS product, 
which is then modified by various reactions to produce Xcn2-6.  Xcn3 to Xcn6 were isolated 
from X. nematophila and X. kozodoii (95).  
 
Fabclavines. A class of peptide-polyketide-polyamino products, called fabclavines, have 
recently been isolated from X. budapestensis and X. szentirmaii (96).  Analysis of the genomes 
of the producer bacteria led to the discovery that the fabclavines are produced by a hybrid PKS-
NRPS gene cluster.  The peptide moiety is synthesized by the FclI and FclJ NRPSs, while the 
PKS, FclK, is responsible for catalyzing the elongation of the peptide moiety’s proline residue.  
These compounds have broad-spectrum activity and are active against Gram-positive and 
Gram-negative bacteria, Saccharomyces cerevisiae, Plasmodium falciparum, 
Trypanosoma brucei and Trypanosoma cruzi.  Furthermore, fabclavines and cationic 
antimicrobial peptides are structurally very similar.  Cationic peptides have massive synergistic 
effects when combined with other antibiotics (97).  Fabclavines may thus also display 
synergistic effects when combined with other antibiotics in the insect cadaver. 
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Xenobactin 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3 Xenorhabdus bioactive compounds (85–89). Bioactive compounds with unknown 
structures include the antibacterial xenoprotec, bicornitun C and D, and the two bacteriocins, 
xenorhabdicin and xenocin. 
  
Xenoamicin R1 R2 R3 R4 
A Butanoyl Methyl Ethyl 1-methylethyl 
B Butanoyl Methyl Ethyl 2-methylpropyl 
C Butanoyl Methyl Ethyl butan-2-yl 
D Acetoyl Methyl Ethyl 2-methylpropyl butan-2-yl 
E Butanoyl Methyl Methyl 2-methylpropyl butan-2-yl 
F Butanoyl H Ethyl 2-methylpropyl butan-2-yl 
G Pentanoyl Methyl Ethyl 2-methylpropyl butan-2-yl 
H H Methyl Ethyl 2-methylpropyl butan-2-yl 
Taxlllaid n R 
A 3 1-methylethyl 
B 3 Phenyl 
C 3 (ρ-OH) Phenyl 
D 2 1-methylethyl 
E 2 Phenyl 
F 1 1-methylethyl 
  
Xenematide R1 R2 
A Indolyl Indolyl 
B Phenyl Phenyl 
C Phenyl Indolyl 
D Indolyl Phenyl 
Xenocoumacin R 
1 and 5 
 
2 and 6 
 
3 
 
4 
 
Taxlllaids 
 
 
Xenematide 
Xenocoumacins 1-4 
 
Pristinamycin IIA 
Xenoamicins 
Xenocoumacins 5 and 6 
 
Xenematides 
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Szentiamide 
Rhabdopeptide 2, 4 and 6 
 
Rhabdopeptide 7 
 
Rhabdopeptide 8 
 
Szentiamide 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3 Continued 
Fabclavine Compound n R1 
Ia 1 2 
 Ib 2 1 
IIa 3 2 
 IIb 4 1 
Xenortide R 
A Phenyl 
B Indolyl 
C Phenyl 
D Indolyl 
Rhabdopeptide R 
1 & 2 
 
3 & 4 
 
5 & 6 
 
Fabclavine 1-4 
Fabclavine 5 
Xenortide A and B 
 
Xenortide C and D 
 
Rhabdopeptide 1, 3 and 5 
 
A2 
A1 
Bicornutin A1 and A2 
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Figure 3 Continued 
PAX R1 R2 
1 Propylamine (3R)-3-hydroxytetradecanoyl 
2 Ethylguanidine (3R)-3-hydroxytetradecanoyl 
3 Propylamine (3R)-3-hydroxypentadecanoyl 
4 Ethylguanidine (3R)-3-hydroxypentadecanoyl 
5 Propylamine (3R,7Z)-3-hydroxytetradec-7-enoyl 
6 Ethylguanidine (3R,7Z)-3-hydroxytetradec-7-enoyl 
7 Propylamine (3R)-3-hydroxyhexadecanoyl 
8 Propylamine (3R)-3-hydroxyoctadecanoyl 
9 Ethylguanidine (3R,9Z)-3-hydroxyhexadec-9-enoyl 
10 Ethylguanidine (3R)-3-hydroxyhexadecanoyl 
11 Ethylguanidine (3R,10Z)-3-hydroxyheptadec-10-enoyl 
12 Ethylguanidine (3R)-3-hydroxyheptadecanoyl 
13 Ethylguanidine (3R,11Z)-3-hydroxyoctadec-11-enoyl 
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Figure 3 Continued 
 
Pristinamycin. Pristinamycin forms part of the streptogramin A family of antibiotics and was 
until recently known to be produced by streptomycetes only.  Pristinamycin consists of 
approximately 30% pristinamycin I and 70% pristinamycin II.  Component II occurs in two 
forms, pristinamycin IIA and IIB, of which IIA is the most abundant (98).  This streptomycete 
antibiotic pristinamycin IIA is, however, also produced by X. nematophila via a hybrid 
PKS/NRPS (99).  The biosynthetic gene clusters for this compound are very similar in 
X. nematophila and Streptomyces pristinaspiralis.  Interestingly, further analysis of 
X. nematophila showed that it does not contain a gene cluster for the biosynthesis of 
pristinamycin IA.  The pxn (pristinamycin IIA, X. nematophila) gene cluster, however, is 
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22 4-methylpentane B 
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associated with transposases, suggesting that the genes were obtained through horizontal gene 
transfer.  This might explain the absence of a pristinamycin IA gene cluster in X. nematophila. 
 
Xenortides. To date four xenortides, namely xenortides A-D, have been identified from 
X. nematophila (83, 84, 100).  These peptides are biosynthesized by a gene cluster consisting 
of two NRPS genes (xndA and xndB).  Xenortides have weak antiprotozoal activity, with the 
tryptamides (xenortides B and D) being more active than the phenylethylamides (xenortides A 
and C), and xenortide B being the most active (100).  
 
Rhabdopeptides. Rhabdopeptides are linear, nonribosomally produced, and structurally 
similar to xenortides.  A total of eight rhabdopeptides have been identified, rhabdopeptides one 
to four are from X. nematophila, and seven and eight are from Xenorhabdus cabanillasii (101).  
Rhabdopeptide 2 has weak cytotoxic activity against myoblasts; 2, 7 and 8 have antiprotozoal 
activity, and 7 and 8 are weakly hemotoxic.  These peptides are produced at high concentrations 
after 4 days of infection but this stagnates after 10 days, suggesting that rhabdopeptides are 
important during the stages of insect bioconversion and nematode reproduction.  The gene 
cluster responsible for the biosynthesis of these peptides consists of a three module NRPS gene, 
RdpABC.  
 
Bicornitun. Xenorhabdus budapestensis produce the arginine rich, bioactive compounds, 
bicornitun A1, A2, B and C (102).  The NRPS responsible for the production of bicornitun A1 
was identified as BicA. This was determined by cloning the bicA gene, which encodes BicA, 
into an expression vector and heterologously expressing bicornitun A1 in Escherichia coli 
(103).  Furthermore, the bicornitun complex (a combination of bicornitun A-C) is cytotoxic 
towards Phytophthora nicotianae by inhibiting colony formation, as well as mycelial growth.  
Erwinia amylovora and Bacillus subtilis is also susceptible to the bicornitun complex. 
 
PAX peptides. PAX peptides 1 to 5 were first identified by Gaultieri et al. (104), as lysine-rich 
cyclolipopeptides produced by X. nematophila. These peptides have antifungal and 
antibacterial activity, however they do not show cytotoxic activity and did not lead to increased 
mortality when injected into insects.  An additional eight PAX peptides were identified and 
their structure elucidated by Fuchs et al. (105).  Three NRPS genes (paxABC) are responsible 
for the biosynthesis of the PAX compounds.  The three NRPSs, PaxA, PaxB and PaxC contains 
three, nine and ten domains, respectively.  
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Cabanillasin and Nemaucin. More recently, another two peptides were isolated, namely 
cabanillasin and nemaucin.  These peptides were isolated from X. cabanillasii and have shown 
significant bioactivity. Cabanillasin is efficient at inhibiting the growth of human pathogenic 
filamentous fungi and yeasts (106). Nemaucin was, however, active against methicillin resistant 
Staphylococcus aureus (MRSA). Common genes are proposed to be involved in the production 
of these two peptides as both compounds have four units of the amino-1 guanidino-butane 
moiety and are produced by the same organism.   Nemaucin is, however, structurally more 
similar to fabclavine 1a from X. budapestensis, than cabanillasin, and differs only by having a 
shorter C-terminal at the peptide moiety (96).  
 
Dithiolopyrrolone derivatives. These derivatives include the two metabolites, xenorhabdins 
and xenorxides.  Xenorhabdins have a typical heterobicyclic pyrrolinonodithiole core, which is 
characteristic of dithiolopyrrolone compounds (107).  Xenorxides, in turn, are structurally 
similar to xenorhabdins and are produced when the sulphur moiety of xenorhabdins is 
oxidized (108).  Xenorhabdins and xenorxides have antibacterial, antifungal and insecticidal 
activities (109–111).  Additionally, some of these dithiopyrrolone derivatives have anticancer 
properties.  The general mode of action for dithiolopyrrolones has been suggested to be the 
inhibition of RNA synthesis (112–116).   
 
Indole-containing compounds. Indole is an aromatic heterocyclic compound, consisting of a 
fused pyrrole- and benzene ring (117).  Various bacterial species produce indole and indole 
derivatives that play a role in the regulation of bacterial physiology (118).  Indole derivatives 
isolated form X. nematophila and X. bovienii are active against Gram-positive and Gram-
negative bacteria, as well as fungi.  Sundar and Chang (119) studied these compounds and 
revealed the mechanism of action as the inhibition of RNA synthesis.  Growing bacteria have 
a relatively narrow range of ppGpp concentrations and indole derivatives increase this 
concentration, leading to a reduction in RNA synthesis and ultimately a reduction in growth 
rate.  Furthermore, Seo et al. (120) identified the indole-containing compound, oxindole, as 
well as indole, also produced by X. nematophila.  These compounds have weak phospholipase 
A2 inhibitory effects.  As mentioned previously, phospolipase A2 is an enzyme required for the 
production of eicosanoids.  Eicosanoids, in turn, are crucial for activating an immune response 
in the insect by modulating and mediating hemocyte behaviour (121).  Therefore, these 
compounds inhibit the immune response of the insect, making it more susceptible to infection 
by microorganisms.  Furthermore, Proschak et al. (122), identified additional indole derivatives, 
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called xenocycloins (A-E), also produced by X. bovienii. These compounds have no 
antibacterial activities, but xenocycloin B and D are active against G. mellonella hemocytes.  
Xenocyloins therefore, also contribute to the insecticidal activity of these bacteria. 
Xenematides, previously discussed under depsipeptides, are also known to contain the indole 
structure.  
 
Another indole containing compound, nematophin, is highly active against MRSA strains 
(123). In a study done by Li, Chen and Webster (124), minimal inhibitory concentrations of 
nematophin and its derivatives against S. aureus strains were determined and it was proven that 
compounds with an α-carbonyl acyl group inhibited the growth of S. aureus.  However, 
compounds where the α-carbonyl acyl group was reduced or transferred to a corresponding α-
methoximino acyl group, bioactivity decreased or disappeared.  It was therefore suggested, that 
this α-carbonyl acyl group is essential for the bioactivity of these compounds.  
 
Unnamed peptides. Two antimicrobial peptides, GP-19 and EP-20, have been isolated from 
X. budapestensis (125).  These peptides show broad-spectrum antimicrobial activity against 
fungi and bacteria, but the mode of action is yet to be unraveled.  GP-19 has a neutral charge 
and is proposed to cause a disruptive effect on the membrane by mobilizing to the cell surface 
and possibly penetrating the membrane.  As EP-20 has a negative charge it most likely does not 
have the same mode of action.  This peptide is proposed to have an intracellular effect, by 
inhibiting cell wall, nucleic acid and protein synthesis. 
 
Benzylideneacetone. The moderately hydrophobic compound, benzylideneacetone, isolated 
from X. nematophila, is active against Gram-negative plant pathogenic bacteria.  This 
compound has been used in the industry for various applications, including as a flavouring 
additive in soaps, cosmetics, detergents and cigarettes, as well as a food additive in candy, 
gelatin, and puddings. Even though it has been used for some time, it was only discovered in 
2004 to have antibacterial activity (126).  Benzylideneacetone also inhibits phospholipases A2, 
which, as described, results in the inhibition of the immune response of the insect (120). 
 
Rhabduscin. Rhabduscin is an insecticidal tyrosine derivative, produced by X. nematophila.  
The insecticidal activity of this compound is achieved by inhibiting the enzyme phenoloxidase 
to a low nanomolar-level with an IC50 measurement of approximately 64.1 nM.  Phenoloxidase 
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is important in the melanization pathway of the insect’s immune system.  Inhibition thereof 
leads to inhibition of one of the primary innate immune responses (127). 
 
Bacteriocins. Xenorhabdus bacteria also produce bacteriocins, for example, xenocin, which is 
produced by X. nematophila.  Interestingly, the antibacterial activity of xenocin was only 
observed when bacterial strains were grown in minimal medium and not in enrichment medium 
such as Luria or nutrient broth.  Xenocin production is triggered by a low iron concentration.  
The role of iron depletion has been proposed to be linked to an iron repressed protein, which 
may act as a toxin receptor on sensitive bacterial strains.  This bacteriocin is therefore, only 
produced in the host larva when nutrient concentrations are low and competition intensifies 
(128).  Another bacteriocin, produced by X. nematophila as well as X. bovienii, the phage tail-
like xenorhabdicin, is bactericidal (87, 129, 130).  Xenorhabdus owes its activity against closely 
related bacteria to these bacteriocins, which are essential for keeping the environment free of 
other Xenorhabdus spp. and its sister genus, Photorhabdus spp.  X. beddingii is also able to 
produce bacteriocins, however these bacteriocins have not been characterized. 
 
Upregulating the Production of Xenorhabdus Antimicrobials 
 
When producing antibiotics, it is of the utmost importance that the fermentation conditions are 
optimal to avoid the squandering of time and money. Antibiotic production in Xenorhabdus has 
been optimized at various time periods, mostly by one research group from the Northwest 
University of Agriculture and Forestry, China. This group focused on antibiotic production by 
X. bovienii YL002 (131, 132) and, X. nematophila TB (133) and YL001 (134), while another 
group focused on a specific X. nematophila strain isolated from S. carpocapsae BJ (135). 
Factors taken into consideration for these studies were the environmental parameters; initial 
medium pH, temperature, rotary speed, inoculation volume, medium volume in flask, 
fermentation time, dissolved oxygen levels and growth media.  
 
As expected, the optimization for specific strains varies. There are, however a few trends in the 
results of these studies. The optimal fermentation conditions are a pH from 6.0 to 8.24, 
temperature of 25-32 °C, rotary speed of 150-220 rpm, inoculation volume of 4-15%, medium 
volume of 54-100 ml/250 ml flask and a fermentation time of 54-72 h. The dissolved oxygen 
level was tested for only X. nematophila YL001 and was optimal when it was shifted during 
fermentation from 70% after the first 18 h to 50% for the remaining 54 h. The optimal growth 
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media was tested for X. nematophila TB and X. bovienii YL002, however, the ingredients and 
amount of each ingredient differs for the respective recipes. 
 
Crawford et al. (136) identified one of the main compounds that leads to increased small 
metabolite production in X. nematophila. Xenorhabdus bacteria are known to produce higher 
concentrations of bioactive compounds when in G. mellonella hemolymph than grown 
in vitro (137). Therefore, it was hypothesized that one or more compounds present in insect 
hemolymph are responsible for activating the production of bioactive compounds. This led to 
the selective purification of G. mellonella hemolymph, which led to the discovery of proline as 
the activating signal. Supplementing bacterial cultures with D-proline did not increase the 
production of bioactive compounds, however L-proline did. L-proline is thought to be a generic 
activating signal as it is present in various insect larvae.  
 
The addition of L-proline to bacterial cultures led to an increase in xenematide, three indole 
derivatives and rhabduscin biosynthesis. Another indole-containing compound that was 
affected by an increase in L-proline is nematophin. This L-proline increase led to a decrease in 
the production of nematophin but an increase in its reduced derivative. L-proline therefore, 
regulates a metabolic shift in this case, rather than an increase in nematophin production. 
 
It is evident that production of bioactive compounds requires optimization of the production 
protocol. This is necessary both for use in industry, as well as in research. The optimization 
process is however not an easy task and extended research is needed for this process, especially 
since the protocol will be specific for each bacterial strain and product desired. 
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Conclusion 
 
Even though Xenorhabdus is not one of the generally known antimicrobial metabolite sources, 
it is clear to see why Pidot et al. (77) refer to it as a neglected antibiotic source.  It is evident 
that Xenorhabdus bacteria are an excellent source for novel antimicrobial metabolites.  Various 
studies (102, 138–141), have revealed the significant potential of these bioactive secondary 
metabolites not only in vitro, but also in vivo.  These studies investigated the use of these 
compounds in only the agricultural industry.  However, these compounds may also be exploited 
in various other industries, including the healthcare and food industries.  
 
A number of papers have been published on Xenorhabdus bacteria and their bioactive 
compounds.  However, this is only the tip of the iceberg.  A study done by Crawford et al. (142), 
stated that the X. nematophila DSM 3370T genome contains various gene clusters encoding 
small molecule antimicrobial metabolites.  The number of potential metabolites estimated to be 
produced by this bacterium vastly exceeds the amount of known antibiotic metabolites.  
Furthermore, it is generally known that different Xenorhabdus species, and even strains, 
produce different bioactive compounds.  Therefore, it is clear that the possibilities regarding 
novel bioactive compounds produced by Xenorhabdus bacteria are virtually endless. 
Furthermore, taking into consideration the current antibiotic resistance crisis, novel antibiotic 
discovery is of the essence and Xenorhabdus bacteria might hold the key to human survival in 
the 21st century. 
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Abstract  
 
Xenorhabdus species are normally closely associated with entomopathogenic nematodes of the 
family Steinernematidae. Strain F2, isolated from Steinernema nguyeni, was identified as 
Xenorhabdus bovienii and strains J194 and SB10, isolated from Steinernema jeffreyense and 
Steinernema sacchari as Xenorhabdus khoisanae, based on phenotypic characteristics and 
sequencing of 16S rRNA and housekeeping genes dnaN, gltX, gyrB, infB and recA. All three 
strains produced antimicrobial compounds that inhibited the growth of Gram-positive and 
Gram-negative bacteria. This is the first report of associations between strains of the symbiotic 
bacteria X. bovienii with S. nguyeni, and X. khoisanae with S. jeffreyense and S. sacchari. This 
provides evidence that strains of Xenorhabdus spp. may switch between nematode species 
within the same clade and between different clades. 
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Introduction 
 
The genus Xenorhabdus (Thomas & Poinar, 1979) belongs to the family Enterobacteriaceae. 
Xenorhabdus bacteria are Gram-negative, asporogenous, facultative anaerobic rods with an 
optimal growth temperature of 28 °C, or less, and are differentiated from other 
Enterobateriaceae by the inability to produce oxidase and reduce nitrate [3, 25]. 
Xenorhabdus spp. produce secondary metabolites that include bacteriocins and antibiotics 
[6, 21]. Two cell variants with different physiological and morphological characteristics exist, 
and are classified as phase I or phase II. Phase I cells absorb certain dyes and produce protease, 
lipase and antibiotics. These characteristics are lost or reduced in phase II cells [2, 5]. 
 
Xenorhabdus species are known to be in a mutually beneficial association with free-living 
infective juveniles (IJs) of the genus Steinernema. These nematodes are pathogenic to various 
insect hosts. When the nematodes locate the host in the soil, they penetrate the insect through 
natural openings and the bacteria are released into the hemocoel. Degradation of the insect leads 
to septicaemia and the host dies within 24 to 48 h. Compounds released by the bacteria protect 
the nematodes against attack from other microorganisms. With completion of its life cycle, the 
nematodes take up the symbionts and leave the host cadaver to infect a new host [1]. In general, 
the Steinernema-Xenorhabdus association is species-specific and strains of a Steinernema 
species are associated with a single Xenorhabdus species only. However, strains of a single 
Xenorhabdus species may be associated with more than one Steinernema species [3]. 
 
During this study Xenorhabdus bacteria were isolated, for the first time, from 
Steinernema nguyeni Malan, Knoetze and Tiedt, Steinernema jeffreyense Malan, Knoetze and 
Tiedt and Steinernema sacchari Nthenga, Knoetze, Berry, Tiedt and Malan. Relatedness of the 
bacteria and their association with the three Steinernema spp. were studied using phenotypic, 
biochemical and molecular methods. 
 
Materials and Methods 
 
Isolation and Maintenance of Cultures 
 
Galleria mellonella L. (Lepidoptera: Phyralidae) larvae were exposed to IJs of S. nguyeni F2 
(KP325084) [17], originally collected from soil beneath an Olea europaea subsp. africana L. 
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tree in the Western Cape, 32°20’23’’S, 18°47’49’’E, S. jeffreyense J194 (KC897093) [18], 
isolated from soil underneath a guava tree in the Eastern Cape, 34°02’730’’S, 24°55’610’’E 
and S. sacchari SB10 (KC633095) [20] isolated from a sugar cane field in KwaZulu-Natal, 
29°0.1’37’’S, 31°35’37’’E. Eighteen hours after exposure to the IJs, the live Galleria larvae 
were sterilized with 98% (v/v) alcohol and pricked close to a proleg, by using a sterile syringe 
[12]. A drop of haemolymph was spread-plated onto Nutrient Agar (Biolab, Biolab Diagnostics, 
Midrand, South Africa), supplemented with 0.025% (w/v) bromothymol blue and 0.004% (w/v) 
triphenyltetrazolium chloride (NBTA), and incubated at 30 °C for 48 h [11, 13]. Single colonies 
that absorbed bromothymol blue were sub-cultured to obtain pure cultures. 
 
Bacterial isolates F2, J194 and SB10 were cultured in Tryptone Soy Broth (TSB, Biolab) and 
stored at -80 °C in the presence of 40% (v/v) glycerol. Escherichia coli DH5α transformants 
were cultured in Luria broth (LB, Biolab), supplemented with 100 µg ampicillin/ml. Indicator 
strains (Bacillus subtilis subsp. subtilis BD170, Listeria monocytogenes EDGE, 
Staphylococcus aureus Xen 5, Pseudomonas aeruginosa Xen 5, Escherichia coli Xen 14 and 
Salmonella typhimurium Xen 26 from the culture collection of the Department of Microbiology, 
Stellenbosch University) were cultured in Brain Heart Infusion (BHI, Biolab), with the 
exception of E. coli Xen 14 that was cultured in LB (Biolab). Escherichia coli DH5α 
transformants and indicator strains were cultured in their respective growth media and stored at 
-80 °C, in the presence of 40% (v/v) glycerol. All assays were performed by using phase I cells, 
i.e. cells that absorbed bromothymol blue from NBTA. 
 
Biochemical Characterization 
 
Gram-reaction, and catalase and oxidase activity were determined as described before [11]. 
Isolates were cultured at 26, 30, 37 and 42 °C for 24 h in TSB and changes in growth determined 
by recording optical cell density (OD) at 600 nm. Media required for optimal growth was 
determined by growing cultures in LB (Biolab), Nutrient Broth (NB, Biolab) and TSB (Biolab). 
Incubation was at 30 °C.  Optical density readings (OD600 nm) were recorded after 24h. 
Lecithinase and DNase activity were determined as described by Ferreira et al. [11]. Lipase 
activity was determined by a modification of the method used by Ferreira et al. [11]. Briefly, 
48 h old cultures were spot-inoculated onto growth media containing 0.1% (w/v) CaCl2 • 2H2O, 
5% (w/v) NaCl, 10% (w/v) peptone and 10% (v/v) Tween (40, 60 or 80, respectively). 
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Biochemical characteristics were determined by using the API 20 NE test strips, according to 
instructions of the manufacturer (BioMérieux, Marcy I’Etoile, France). Strips were incubated 
for 10 days at 30 °C. 
 
Antibacterial Activity 
 
Xenorhabdus isolates were spot-inoculated onto TSA plates and incubated at 30 °C for 24, 48, 
72 and 96 h, respectively. After incubation, colonies were overlaid with BHI agar (1%, w/v), 
seeded with a 12 h-old culture of B. subtilis subsp. subtilis BD170 (1%, v/v). The same method 
was used to overlay 96 h-old colonies with the remainder of the indicator strains used in this 
study. All plates were incubated at 37 °C for 24 h and examined for the presence of growth 
inhibition (clear zones surrounding the colonies). 
 
Phylogenetic Analysis of Isolates 
 
A modification of the method described by Crouse and Amorese [9] was used to extract 
genomic DNA. Polymerase chain reaction (PCR) was used to amplify the 16S rRNA gene and 
housekeeping genes glutamyl-tRNA synthetase catalytic subunit (gltX) and DNA polymerase 
III beta chain (dnaN). PCR amplifications were performed by using Q5® High-Fidelity DNA 
Polymerase (Thermo Fisher Scientific, Waltham, Massachusetts, USA) or GoTaq® HotStart 
DNA Polymerase (Promega Corporation, Madison, Wisconsin, USA) in a SwiftMinipro 
thermal cycler (Esco Healthcare, Malaysia). Primers for the housekeeping genes and 16S rRNA 
were obtained from Integrated DNA Technologies (Coralville, Iowa, USA) and Inqaba 
Biotechnology (Pretoria, South Africa), respectively. Oligonucleotide sequences are listed in 
Table S1. Amplified genes were sequenced by the DNA sequencing unit, Central Analytical 
Facility (CAF), University of Stellenbosch, South Africa. 
 
A Whole Genome Sequencing (WGS) approach was used to clarify the exact species of isolates 
J194 and SB10. Genomic DNA was mechanically fragmented using the Covaris® M220 
Focused-Ultrasonicator™ (Thermo Fisher Scientific, Waltham, MA, USA). Sequencing 
libraries were prepared by using the NEBNext® Ultra™ DNA Library Prep Kit (New England 
Biolabs Inc., Ipswich, MA, USA) and the Illumina® NEBNext® Multiplex Oligos (New 
England Biolabs Inc.) before sequencing the genomic DNA on the Illumina® Miniseq 
(Illumina,  San Diego, California, USA). This service was delivered by the Centre for Proteomic 
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and Genomic Research, for isolates J194 and SB10, and X. miraniensis Q1T. Whole genome 
sequencing for X. khoisanae SF87T was performed on the Ion Proton (CAF). Accession 
numbers are SAMN06841127, SAMN06841126, SAMN06841131 and SAMN06841128 for 
J194, SB10, X. khoisanae SF87T and X. miraniensis Q1T, respectively. 
 
Illumina PE reads for each strain were de novo assembled with Velvet v1.2.10 [29] and SPAdes 
v3.10.1 [4].  SPAdes v3.10.1 yielded better assemblies and larger contigs based on the assembly 
statistics [16, 26]. Contigs containing the 16S rDNA, dnaN, gltX, DNA gyrase subunit B (gyrB), 
initiation factor B (infB) and recombinase A (recA) genes were identified by BLASTn v2.6.0+ 
[7, 28] analysis against respective gene reference sequences. Each gene with approximately 500 
bp of up and down stream regulatory elements was used to compare isolates SB10 and J194 to 
strains, X. khoisanae SF87T and X. miraniensis Q1T by BLASTn analyses. 
 
Additional gene sequences of type strains of Xenorhabdus spp. were obtained from the National 
Center for Biotechnology Information (NCBI). These sequences and sequences obtained from 
this study were aligned and trimmed by using MEGA6.0 [24]. Distance matrices were 
calculated by the Kimura two-parameter model [14]. Phylogenetic trees were constructed by 
using the maximum-likelihood method and bootstrapping with 1000 replicates (MEGA6.0). 
Translated BLAST searches (BLASTx, NCBI) were performed with protein-coding sequences. 
 
DNA sequences were uploaded to NCBI. Strain F2 with accession numbers KT954036, 
KT954029 and KT954034 for genes 16S rRNA, gltX and dnaN, respectively. Strain SB10 with 
accession numbers KT954037, KT954026 and KX925557 for genes 16S rRNA, gltX and dnaN, 
respectively. Lastly, strain J194 with accession numbers KX925559, KT954027 and KX925558 
for genes 16S rRNA, gltX and dnaN, respectively. Gene sequences range from 1371 to 1524, 
1009 to 1167 and 995 to 1095 nT for genes 16S rRNA, gltX and dnaN, respectively. Additional 
phylogenetic trees are shown in supplementary Figs. S1-S3. 
 
Results and Discussion  
 
All isolates were Gram-negative, rod-shaped, and oxidase and catalase negative. Colonies were 
dark blue-green on NBTA. Optimal growth was between 26 and 30 °C. Similar growth was 
recorded on NB, LB and TSB. All three strains were negative for lecithinase activity and were 
unable to reduce nitrate. Isolate F2 had no DNase or lipase activity, but produced indole from 
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tryptophan. DNase activity was reported for isolates J194 and SB10. Isolate SB10 showed 
lipase activity on plates containing Tween 40. D-glucose, D-mannose, N-acetyl-glucosamine, 
D-maltose, potassium gluconate, adipic acid, malic acid, trisodium citrate and phenylacetic acid 
were assimilated. Esculin and gelatin were hydrolysed by all three isolates (F2, J194 and SB10). 
 
Maximum antibacterial activity was recorded after 72 h of incubation. The growth of all 
indicator strains was inhibited, except P. aeruginosa Xen 5. Most Xenorhabdus spp. produce a 
range of bioactive secondary metabolites [27]. This is most likely the case with the three 
isolates, as they clearly inhibited the growth of Gram-positive and Gram-negative bacteria. 
Growth of P. aeruginosa Xen 5 was not inhibited, most possibly due to the low concentration 
of the secondary metabolites produced. 
 
Sequences obtained for 16S rRNA, gltX and dnaN of strain F2 shared 98-99% similarity (97-
99% DNA coverage) with sequences reported for Xenorhabdus bovienii T228T. The 
phylogenetic tree constructed from concatenated sequences of 16S rRNA, gltX and dnaN 
(Fig. 1) grouped strain F2 with X. bovienii T228T. The same grouping was obtained with 
comparison of individual gene sequences and protein sequences (Table S2). This is the first 
report of X. bovienii associated with the entomopathogenic nematode S. nguyeni. 
Xenorhabdus bovienii is also associated with closely related members of the Feltiae-clade 
(based on ITS and D2-D3 regions), which include Steinernema affine (Bovien) Wouts, Mráček, 
Gerdin and Bedding, Steinernema feltiae (Filipjev) Wouts Mráček, Gerdin and Bedding, 
Steinernema intermedium (Poinar) Mamiya, Steinernema kraussei (Steiner) Travassos, 
Steinernema jollieti Spiridonov, Krasomil-Osterfeld and Moens, Steinernema oregonense Liu 
and Berry, Steinernema puntauvense Uribe-Lorio, Mora and Stock and Steinernema weiseri 
Mráček, Sturhan and Reid [23]. Xenorhabdus bovienii is not only associated with Steinernema 
species in the Feltiae-clade, but also with species in the Affine-clade, including 
Steinernema affine (Bovien) Wouts, Mráček, Gerdin & Bedding and Steinernema intermedium 
(Poinar) Mamiya [23]. 
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Fig. 1 Phylogenetic position of isolates F2, J194 and SB10 based on concatenated sequences of 
genes, 16S rDNA, gltX and dnaN. Photorhabdus spp. were used as outgroups and type strains 
are indicated by superscript letter T. Bootstrap values below 70% are not shown. 
 
Nucleotide similarity searches suggested that isolates J194 and SB10 belong to the species 
X. khoisanae with a similarity of 96-99%. Figure 1 indicates, as supported by the putative 
identification based on nucleotide and protein similarities, that isolates J194 and SB10 are 
additional strains belonging to the species X. khoisanae. Previous studies have identified five 
strains of X. khoisanae, strains SF 87T, SF80, SF362 and 106-C all isolated from S. khoisanae 
[10] and strain MCB isolated from an unidentified Steinernema sp. [19]. This study reports that 
X. khoisanae is additionally associated with S. jeffreyense and S. sacchari. 
Steinernema jeffreyense belongs to the glaseri-group of which the IJs are larger than 1000 µm 
and molecularly related to clade V [22]. However, S. sacchari belongs to the new monophyletic 
group, the Cameroonian clade (clade III), which is closely related to the feltiae-kraussei-
oregonense group, with IJs between 700-1000 µm [20]. Concluded from these reports, 
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X. khoisanae has the ability to switch between nematodes of distantly related clades (between 
clades V and III). In a recent report, Çimen et al. [8] have shown that Steinernema beitlechemi 
Çimen, Půža, Nermu, Hatting, Ramakuwela, Faktorová and Hazir, a new entomopathogenic 
nematode from South Africa and a member of the Cameroonense-clade closely related to 
S. sacchari, is also a host to X. khoisanae. The authors based their findings on 16S rRNA gene 
sequences only. Lee and Stock [15] have shown at least 17 host switches of strains of 
Xenorhabdus spp. within clades and even between clades. Stock [23] also reported the 
switching of strains of Xenorhabdus nematophila (Poinar & Thomas) from clade IV to a more 
distantly related nematode host in clade II. 
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Supplementary material 
 
Table S1 Oligonucleotides 
Target gene Primer Oligonucleotide sequence (5’ to 3’) Tm (°C) Product 
size (bp) 
gltX gltX1 (F)  GGCACCAAGTCCTACTGGCTA 56.6 1258 
gltX2 (R)  GGCATRCCSACTTTACCCATA 55.9 
dnaN dnaN1 (F) GAAATTYATCATTGAACGWG 
 
46.0 1091 
dnaN2 (R) CGCATWGGCATMACRAC 
 
51.4 
16S rDNA F8 (F) CAGGCATCCAGACTTTGATYMTGGCT
CAG  
 
55.0 +/- 1600 
R1512 (R) GTGAAGCTTACGGYTAGCTTGTTACG
ACTT  
55.0 
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Table S2 Protein similarity of protein-coding genes using BLASTx 
Isolate Protein-
coding gene 
Nearest Similarity 
Organism Protein size 
(aa) 
Identity (%) Accession number 
F2 gltX X. bovienii 471 99 WP_038186822.1 
 dnaN X. bovienii 366 99 WP_038247914.1 
J194 gltX X. khoisanae 171 98 WP 047961607.1 
 dnaN X. khoisanae 331 99 WP_047962545.1 
 recA X. khoisanae 358 99 WP_047961634.1 
 gyrB X. khoisanae 804 99 WP_047962547.1 
 infB X. khoisanae 923 99 WP_047962383.1 
SB10 gltX X. khoisanae 171 98 WP 047961607.1 
 dnaN X. khoisanae 330 99 WP_047962545.1 
 recA X. khoisanae 358 100 WP_047961634.1 
 gyrB X. khoisanae 804 99 WP_047962547.1 
 infB X. khoisanae 923 99 WP_047962383.1 
 
 
Stellenbosch University  https://scholar.sun.ac.za
 
 
57 
 
 
Fig. S1 Phylogenetic relationship of isolates F2, J194 and SB10 with other Xenorhabdus spp. 
based on the 16S rDNA sequence, using the maximum likelihood method. Photorhabdus spp. 
were used as outgroups and type strains are indicated by T. Bootstrap values of more than 70% 
are shown at branch points. 
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Fig. S2 Phylogenetic relationship of isolates F2, J194 and SB10 with other Xenorhabdus spp. 
based on the gltX protein-coding sequence, using the maximum likelihood method. 
Photorhabdus spp. were used as outgroups and type strains are indicated by T. Bootstrap values 
of more than 70% are shown at branch points. 
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Fig. S3 Phylogenetic relationship of isolates F2, J194 and SB10 with other Xenorhabdus spp. 
based on the dnaN protein-coding sequence, using the maximum likelihood method. 
Photorhabdus spp. were used as outgroups and type strains are indicated by T. Bootstrap values 
of more than 70% are shown at branch points. 
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Abstract  
 
Strain WS9, a mutualistic-associated bacterium, was isolated from an unknown 
entomopathogenic Steinernema nematode, collected from a litchi orchard in Friedenheim, 
Mpumalanga, South Africa. Based on phenotypic and phylogenetic data of the 16S rRNA, gltX, 
recA, dnaN, gyrB and infB gene sequences, strain WS9 is identified as X. griffiniae. Strain WS9 
has antibacterial activity against Gram-positive and Gram-negative bacteria. This is the first 
report of an association between X. griffiniae and an unknown Steinernema species from South 
Africa. 
 
Keywords Entomopathogenic nematodes • Mutualistic bacterium • Taxonomy • 16S rRNA 
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Introduction 
 
Members of the genus Xenorhabdus are Gram-negative, asporogenic, fermentative, facultative 
anaerobic rods with a respiratory and fermentative metabolism, and belongs to the family 
Enterobacteriaceae. They grow optimally at 28 °C, are oxidase and catalase negative and do not 
reduce nitrate to nitrite (Thomas and Poinar 1997; Akhurst and Boemare 2005). Acid is 
produced from the fermentation of glucose, but without the release of CO2. N-acetyl-
glucosamine, glycerol, fructose and mannose are usually fermented (Akhurst and Boemare 
2005). Xenorhabdus species are known to produce two phenotypic variants that differ in 
morphology and physiology. Phase I cells are larger than phase II cells, absorb certain dyes and 
produce proteases, lipases and antibiotics (Akhurst 1980; Boemare and Akhurst 1988). 
 
Xenorhabdus spp. are closely associated with entomopathogenic nematodes of the family 
Steinernematidae that infects insects such as Lepidoptera, Diptera, Orthoptera, Coleoptera and 
Hymenoptera (Laumond et al. 1979; Poinar 1979). Although the association between 
Xenorhabdus spp. and nematodes is species-specific, a single species may infect different 
Steinernema spp. (Fischer-Le Saux et al. 1997; Lee and Stock 2010). More than twenty 
Xenorhabdus species have been characterized, with approximately eleven of these species being 
associated with more than one Steinernema nematode species (Tailliez et al. 2006; Stock 2015). 
 
Steinernema dauer larvae or non-feeding infective juvenile (IJ) transport Xenorhabdus to the 
hemocoel by entering natural openings on the body of the insect. Once in the hemocoel, the IJ 
nematodes release an immune-suppressive agent that suppresses the activity of antimicrobial 
peptides produced by the insect (Götz et al. 1981). IJ develop into amphimictic females and 
males that feeds on the proliferating bacteria. Endo- and exotoxins (e.g. DNases, lipases and 
lecithinases) are released by the bacteria, killing the insect within 24 to 48 h. Colonization of 
the cadaver by other microorganisms is prevented by the release of antimicrobial compounds 
from the respective Xenorhabdus species. The bacteria and bio-converted host tissue supports 
the sexual reproduction of the nematodes as long as nutrients are available. The nematodes, 
colonized with a few cells of Xenorhabdus are then released into the environment to repeat the 
cycle of infection (Adams and Nguyen 2002). 
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In this study, the bacterial strain WS9 was isolated from an unknown entomopathogenic 
nematode Steinernema sp. WS9. The bacteria were identified using phenotypic and genotypic 
characteristics.  
 
Materials and Methods 
 
Isolation of Xenorhabdus sp. and Maintenance of Cultures 
 
Galleria mellonella L. (Lepidoptera: Pyralidae) larvae were exposed to IJs of 
Steinernema sp. WS9 (KP325086; MF443108) collected from a litchi orchard in Friedenheim 
(25°30.927’S 30°58.681’E), Mpumalanga, South Africa. After 18 h, the live Galleria larvae 
were dipped in 98% alcohol, bent and pricked close to a proleg, using a sterile syringe. A drop 
of hemolymph, was spread-plated onto Nutrient Agar (NA, Biolab, Biolab Diagnostics, 
Midrand, South Africa), supplemented with 0.025% (w/v) bromothymol blue and 0.004% (w/v) 
triphenyltetrazolium chloride (TTC), known as NBTA (Kaya and Stock 1997; Ferreira et al. 
2013). The plates were incubated at 30 ˚C for 48 h. Colonies that absorbed bromothymol blue 
were regarded as Xenorhabdus spp. and streaked onto NBTA to obtain pure cultures. 
 
Strain WS9, isolated from one colony, was cultured in Tryptone Soy Broth (TSB, Biolab) and 
stored at -80 ˚C in cryotubes with 40% (v/v) glycerol. All experiments were performed with 
phase I cells, stored in glycerol, to prevent phase shifting. Phase I cells were differentiated from 
phase II cells by the absorption of bromothymol blue from NBTA plates. All assays were 
performed with cultures from glycerol to prevent phase shifting. Escherichia coli Xen 14 was 
cultured in Luria broth (LB, Biolab) and E. coli DH5α transformants in LB, supplemented with 
100 µg ampicillin/ml. Bacillus subtilis subsp. subtilis BD170, Listeria monocytogenes EDGE, 
Staphylococcus aureus Xen 5, Pseudomonas aeruginosa Xen 5 and Salmonella typhimurium 
Xen 26 were cultured in Brain Heart Infusion (BHI, Biolab). Stock cultures were prepared in 
40% (v/v) glycerol and stored at -80 ˚C. 
 
Cell Morphology and Phenotypic Characteristics 
 
Strain WS9 was gram stained and the size of a single cell determined using a Leica DM2000 
research microscope (Leica Microsystems), equipped with a camera, computer and digital 
image software [Leica Application Suite (LAS), version 3.5.0]. Oxidase activity was 
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determined using Kovács oxidase reagent. Catalase activity was recorded by suspending a 
colony in a drop of 5% (v/v) H2O2. Optimal growth temperature was determined by growing 
cultures at 26 °C, 30 °C, 37 °C and 42 °C for 24 h in TSB. Changes in growth were monitored 
by recording optical density readings at 600 nm. Lecithinase activity was determined as 
described by Ferreira et al. (2013). Lipase activity was determined by streaking 48 h-old 
cultures onto media containing 10% (w/v) peptone, 5% (w/v) sodium chloride, 0.1% (w/v) 
CaCl2 • 2H2O and either 10% (v/v) Tween 40, Tween 60 or Tween 80. All experiments were 
done in triplicate. 
 
Carbohydrate fermentation and assimilation profiles were determined using API 50 CHE and 
20 NE test strips, respectively (BioMérieux, Marcy I’Etoile, France), according to the 
instructions of the manufacturer. Results were recorded after 10 days of incubation at 30 ˚C. 
 
Genotypic Characterization and Phylogenetic Analysis 
 
Genomic DNA was extracted using a modification of the method described by Crouse and 
Amorese (1987). The 16S rDNA and housekeeping genes glutamyl-tRNA synthetase catalytic 
subunit (gltX), recombinase A (recA) and DNA polymerase III beta chain (dnaN) were amplified 
by using the primers listed in Table 1. 16S rDNA primers were from Inqaba Biotechnology 
(Pretoria, South Africa) and all other primers from Integrated DNA Technologies (Coralville, 
Iowa, USA). Amplifications were performed using Q5® High-Fidelity DNA Polymerase 
(Thermo Fisher Scientific, Waltham, Massachusetts, USA) or GoTaq® HotStart DNA 
Polymerase (Promega Corporation, Madison, Wisconsin, USA) and a SwiftMinipro thermal 
cycler (Esco Healthcare, Malaysia). Amplified fragments were ligated into plasmids pGEM®T 
Easy (Promega Corporation) or pJET1.2 (Thermo Fisher Scientific), according to instructions 
of the manufacturer. The plasmids were transformed to E. coli DH5α and cloned cells selected 
from colonies on LB agar supplemented with 100 µg/ml ampicillin. Positive clones were 
confirmed by sequencing. The sequencing facilities at the DNA sequencing unit, Central 
Analytical Facility, University of Stellenbosch, were used. 
 
Whole Genome Sequencing (WGS) was used to determine the precise species of isolate WS9. 
Genomic DNA was sequenced on the Illumina Miniseq (Illumina, San Diego, California, USA) 
instrument. Before sequencing, genomic DNA was fragmented by using the M220 Focused-
Ultrasonicator (Thermo Fisher, Waltham, MA, USA). The NEBNext® Ultra™ DNA Library 
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Prep Kit and Illumina® NEBNext® Multiplex Oligos (New England Biolabs Inc., Ipswich, 
MA, USA) were used for preparing sequencing libraries. This service was delivered by the 
Centre for Proteomic and Genomic Research (CPGR). The accession number for the WGS data 
of strain WS9 is SAMN07327420.  
 
Table 1 Primers used for sequencing 
Target gene Primer Oligonucleotide sequences (5’-3’)  Tm (°C) Product size (bp) 
gltX gltX1  GGCACCAAGTCCTACTGGCTA (F) 56.6 1258 
gltX2   GGCATRCCSACTTTACCCATA (R) 55.9 
recA recA1  GCTATTGATGAAAATAAACA (F) 43.7 893 
recA2  RATTTTRTCWCCRTTRTAGCT (R) 48.8 
dnaN dnaN1  GAAATTYATCATTGAACGWG (F) 46.0 1091 
dnaN2 CGCATWGGCATMACRAC (R) 51.4 
16S rDNA F8 (F) CAGGCATCCAGACTTTGATYMTGGCTCAG (F) 55.0 Approx.1600 
R1512  GTGAAGCTTACGGYTAGCTTGTTACGACTT (R)  55.0 
 
De novo assemblies of Illumina PE reads were constructed by using SPAdes v3.10.1. Contigs 
containing the 16S rDNA and housekeeping genes, gltX, recA, dnaN, DNA gyrase B (gyrB) and 
initiation factor B (infB) were identified by using BLASTn v2.6.0+ analysis and compared to 
respective gene reference sequences. MEGA6.0 (Tamura et al. 2013) was used to align 
sequences. The maximum-likelihood method was used to construct phylogenetic trees from 
single gene sequences and concatenated sequences. The Kimura two-parameter model 
(Kimura 1980) was used to calculate the distance metrics for aligned sequences. The robustness 
of individual branches was determined by bootstrapping with 1000 replicates. Parameters were 
kept constant for the construction of all phylogenetic trees. Protein-coding sequences were 
compared to previously published sequences by performing translated BLAST searches 
(BLASTx, National Center for Biotechnology Information). Gene sequences of closely related 
species and outgroups were obtained from the National Center for Biotechnology Information 
(NCBI). 
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Testing for Antibacterial Activity 
 
Antibacterial activity was determined by spotting 5 µl of a 12 h-old culture of WS9 onto TSB 
agar (TSA). The plates were incubated at 30 °C for 24, 48, 72 and 96 h, respectively, and then 
overlaid with 12 h-old cells of B. subtilis subsp. subtilis BD170 suspended in BHI agar 
(1%, w/v). Spot inoculated plates that were incubated for 96 h were overlaid with 
L. monocytogenes EDGE, S. aureus Xen 5, P. aeruginosa Xen 5 and S. typhimurium Xen 26, 
each suspended in BHI agar (1%, w/v), and E. coli suspended in LB agar (1%, w/v). Results 
were recorded after 24 h of incubation at 37 ˚C. 
 
Results and Discussion 
 
Phenotypic and Biochemical Characteristics 
 
Strain WS9 is Gram-negative, rod-shaped and 0.8-1.1 by 3.1-6.2 µm in size. Catalase and 
oxidase were not produced. All colonies absorbed bromothymol blue from NBTA plates, which 
is characteristic for Xenorhabdus spp. (Kaya and Stock 1997). Optimal growth was recorded at 
26 and 30 °C, with slightly better growth at 30 °C. Strain WS9 does not produce lecithinase, 
and is negative for the hydrolysis of Tweens 60 and 80, but positive for Tween 40. 
 
Strain WS9 produced acid from the fermentation of ribose, xylose, glucose, fructose, mannose, 
dulcitol, N-acetylglucosamine, maltose, melibiose, gentobiose and fucose. Acid production 
from glycerol, arabinose, galactose, inositol, manitol, esculin ferric citrate, trehalose, luxose, 
arabitol and potassium gluconate was weak. Strain WS9 assimilated glucose, mannose, N-cetyl-
glucosamine, maltose, potassium gluconate, adipic acid, malic acid, trisodium citrate and 
phenylacetic acid. No other tested carbohydrates were metabolized. Nitrate was not reduced to 
nitrite. 
 
Antibacterial Activity 
 
The antibacterial activity of strain WS9 reached maximum level after 72 h of growth. Colonies 
of strain WS9 inhibited the growth of B. subtilis subsp. subtilis BD170, L. monocytogenes 
EDGE, S. aureus Xen 5, E. coli Xen 5 and S. typhimurium Xen 26. No antibacterial activity 
was recorded against P. aeruginosa Xen 5, which is most likely due to a low secondary 
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metabolite concentration. Most Xenorhabdus spp. produce one or more antimicrobial 
compounds (Webster et al. 2002). Further research is required to identify the antibacterial 
compounds produced by strain WS9. 
 
Phylogenetic Analysis of Strain WS9 
 
Strain WS9, grouped with the type strain of X. griffiniae when 16S rDNA, gltX, recA, dnaN, 
gyrB and infB sequences were concatenated (Fig. 1). Comparison of 16S rDNA, gltX, dnaN and 
gyrB sequences (Online Resources 1 to 4), separately, grouped strain WS9 with X. griffiniae, 
but with X. ehlersii and Xenorhabdus sp. TZ01 (JQ687358; JQ687369–JQ687373) when 
sequences of recA and infB (Online Resources 5 and 6) were compared. This suggests that strain 
WS9 is phylogenetically related to X. griffiniae and, to a lesser extent to X. ehlersii and 
Xenorhabdus sp. TZ01. Nucleotide similarity searches produced lower identity percentages for 
X. ehlersii and Xenorhabdus sp. TZ01 compared to X. griffiniae, despite the fact that query 
coverages were similar, with exception of the recA gene (Online Resource 7). Protein-coding 
sequences of gltX, dnaN and gyrB obtained for isolate WS9 were similar, but not identical, to 
protein-coding sequences listed for X. griffiniae (Online Resource 7). However, corresponding 
to phylogenetic trees, protein-coding sequences for recA and infB, were similar to those of 
X. ehlersii and Xenorhabdus sp. TZ01, respectively.  Taking into consideration all the above 
mentioned, the bacterial isolate WS9 has been identified as a strain belonging to the species 
X. griffiniae. Closely related X. ehlersii has been isolated from Steinernema longicaudum Shen 
& Wang (syn. Steinernema serratum) (Lengyel et al. 2005; Tailliez et al. 2006), and 
Xenorhabdus sp. TZ01 from Steinernema pwaniensis (Půža et al. 2016). The Steinernema sp. 
strain WS9 is closely related to S. pwaniensis from Tanzania, and both belongs to the Karii-
clade, while S. longicaudum belongs to the Longicaudum-clade (Spiridonov and Subbotin 
2017). 
 
Xenorhabdus griffiniae has previously been isolated from the nematode 
Steinernema hermaphroditum Stock, Griffin & Chaerani (Nguyen and Hunt 2007) and more 
recently from the nematode Steinernema khoisanae strain BMMCB (Mothupi et al. 2015).  
Based on the internal transcribed spacer (ITS) region (KT027382), S. khoisanae BMMCB is 
91% similar to the type species, S. khoisanae SF80 (DQ314287), and 92% to Steinernema sp. 
strain WS9 (KP325086). According to Nguyen & Hunt (2007) a sequence similarity in the ITS 
region of 95% or less to the most closely related species indicate a possible new Steinernema 
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species. This suggests that strain BMMCB could be neither S. khoisanae nor Steinernema sp. 
WS9, but appears to be a new Steinernema species. 
 
 
Fig. 1 Phylogenetic relationship of strain WS9 with known Xenorhabdus spp. The maximum 
likelihood tree was constructed using concatenated sequences of six genes (16S rDNA, gltX, 
recA, dnaN, gyrB and infB). Three Photorhabdus spp. were used as outgroups. Type strains are 
indicated by a superscript T. Bootstrap values of more than 70% are shown at branch points. 
The bar indicates a sequence divergence of 2%. 
 
Previously, Spiridonov et al. (2004) grouped all three nematode species associated with 
Xenorhabdus griffiniae in one clade (clade V). According to recent molecular information 
(Spiridonov & Subbotin, 2017), the two nematode species associated with X. griffiniae belong 
to different clades; Steinernema sp. WS9 to the Karii-clade and S. hermaphroditum to the 
Longicaudum-clade.  Host switches of the bacterial symbionts are generally observed between 
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nematodes belonging to the same clade, however increasing reports have shown that host 
switches can occur between nematodes from different clades, which is also the case for this 
study (Lee and Stock 2010; Çimen et al. 2016; Dreyer et al. 2017). 
 
This study reports, for the first time, an association between X. griffiniae and an unknown 
locally isolated Steinernema sp. WS9.  Accession numbers for the PCR obtained sequences 
16S rDNA, gltX, recA and dnaN are KT954035, KT954028, KT954030 and KT954033, 
respectively. 
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Online Resources 
 
 
Online Resource 1. Phylogenetic position of strain WS9 with known Xenorhabdus spp. based 
on 16S rDNA sequences. Three Photorhabdus spp. were used as outgroups. Type strains are 
indicated by a superscript T. Bootstrap values of more than 70% are shown at branch points. A 
sequences divergence of 0.5% is indicated by the bar. 
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Online Resource 2. Phylogenetic position of strain WS9 with known Xenorhabdus spp. based 
on gltX protein-coding sequences. Three Photorhabdus spp. were used as outgroups. Type 
strains are indicated by a superscript T. Bootstrap values of more than 70% are shown at branch 
points. A sequences divergence of 2% is indicated by the bar. 
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Online Resource 3. Phylogenetic position of strain WS9 with known Xenorhabdus spp. based 
on dnaN protein-coding sequences. Three Photorhabdus spp. were used as outgroups. Type 
strains are indicated by a superscript T. Bootstrap values of more than 70% are shown at branch 
points. A sequences divergence of 5% is indicated by the bar. 
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Online Resource 4. Phylogenetic position of strain WS9 with known Xenorhabdus spp. based 
on gyrB protein-coding sequences. Three Photorhabdus spp. were used as outgroups. Type 
strains are indicated by a superscript T. Bootstrap values of more than 70% are shown at branch 
points. A sequences divergence of 5% is indicated by the bar. 
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Online Resource 5. Phylogenetic position of strain WS9 with known Xenorhabdus spp. based 
on recA protein-coding sequences. Three Photorhabdus spp. were used as outgroups. Type 
strains are indicated by a superscript T. Bootstrap values of more than 70% are shown at branch 
points. A sequences divergence of 2% is indicated by the bar. 
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Online Resource 6. Phylogenetic position of strain WS9 with known Xenorhabdus spp. based 
on infB protein-coding sequences. Three Photorhabdus spp. were used as outgroups. Type 
strains are indicated by a superscript T. Bootstrap values of more than 70% are shown at branch 
points. A sequences divergence of 2% is indicated by the bar. 
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Online Resource 7. Putative identification of isolate WS9 based on nucleotide and protein-coding similarities, using BLASTn and BLASTx, 
respectively. 
Gene Nucleotide Protein-coding 
Nearest similarity Query 
coverage 
(%) 
Nucleotide 
identity 
(%) 
Accession 
number 
Nearest similarity Protein 
(aa) 
Protein 
identity 
(%) 
Accession number 
gltX X. griffiniae ID10 100 98 FJ840496.1 X. griffiniae ID10  352 99 ACZ13593.1 
recA X. ehlersii DSM16337 99 96 FJ823398.1 X. ehlersii DSM16337 215 100 ACZ13497.1 
dnaN X. griffiniae ID10 100 98 FJ831449.1 X. griffiniae ID10 276 99 ACZ13534.1 
gyrB X. griffiniae ID10 100 98 EU934525.1 X. griffiniae ID10 287 99 ACL68114.1 
infB X. griffiniae ID10 100 98 JF798405.1 Xenorhabdus sp. TZ01 320 100 AFZ40448.1 
16S rDNA X. griffiniae ID10 100 99 NR043643.1 Not applicable 
 
Stellenbosch University  https://scholar.sun.ac.za
Stellenbosch University  https://scholar.sun.ac.za
 
 
80 
 
 
 
 
 
 
 
Chapter 5 
Novel Antimicrobial Compounds Produced by 
Xenorhabdus khoisanae SB10, and the First 
Report on PAX peptides, Xenocoumacins and 
Xenorhabdins from this Species 
  
Stellenbosch University  https://scholar.sun.ac.za
 
 
81 
 
Novel Antimicrobial Compounds Produced by Xenorhabdus khoisanae SB10, and the 
First Report on PAX peptides, Xenocoumacins and Xenorhabdins from this Species 
 
J. Dreyer1, E. Booysen1, M. Rautenbach2, A.D. van Staden1, S.M. Deane1 and L.M.T. Dicks1 
 
1Department of Microbiology, University of Stellenbosch, Private Bag X1, 7602 Matieland, 
South Africa  
2 Department of Biochemistry, University of Stellenbosch, Private Bag X1, 7602 Matieland, 
South Africa 
 
Abstract 
 
Xenorhabdus species are known to produce various bioactive compounds. Here we report on 
antimicrobial compounds produced by Xenorhabdus khoisanae SB10, a strain isolated from 
the nematode Steinernema sacchari SB10T. Xenorhabdus khoisanae SB10 was incubated on 
solid media and treated with XAD-16 beads to isolate compounds with hydrophobic properties. 
Sep-Pak C18 chromatography was used for purification. Further purification was by two 
separate methods; FPLC and HPLC, and a two-step HPLC method. Characterization was done 
by subjecting the active fractions to UPLC (Ultra-Performance Liquid Chromatography) 
coupled to ESI-MS (Electrospray Ionization Mass Spectrometry). Four novel antimicrobial 
compounds with mass-to-charge (m/z) ratios of 671.41 m/z, 434.27 m/z, 341.15 m/z and 
259.17 m/z were identified. This is the first report of a X. khoisanae strain producing PAX 
peptides, xenocoumacins and xenorhabdins.  
 
Keywords Xenorhabdus khoisanae, antimicrobial compounds, FPLC, HPLC, UPLC, ESI-MS   
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Introduction 
 
Xenorhabdus bacteria are mutualistically associated with Steinernema nematodes and form a 
species-specific association, i.e. a specific Steinernema sp. is associated with a specific 
Xenorhabdus sp. At the beginning of the Xenorhabdus-Steinernema life cycle, nematodes in 
the infective juvenile phase infect the insect host by entering the mouth, anus or respiratory 
spiracles. Once inside the insect, the nematodes release the symbiotic bacteria by defecation. 
Steinernema nematodes produce proteins that suppress the insect’s immune response, which 
allows Xenorhabdus to multiply (1). The release of exoenzymes and toxins by both mutualists 
leads to septicemia and the insect dies within 24-48 h after infection (2–4). Nematodes 
reproduce sexually by going through phases J1 to J4 until resources are depleted, after which 
they return to the infective juvenile state, take up symbionts and leave the cadaver in search of 
a new host. During the life cycle, Xenorhabdus produce various antimicrobial compounds to 
create a semi-exclusive environment and prevent colonization of the host (insect) by other 
microorganisms (5). 
 
In 1959, Dutky (6) was the first to suggest Xenorhabdus bacteria produce antimicrobial 
compounds. However, interest in antimicrobial compounds produced by these bacteria only 
started to increase 22 years later (7). Numerous bioactive compounds have been identified from 
Xenorhabdus spp., which include broad-spectrum compounds with activity against bacteria, 
fungi, insects, nematodes, protists and even cancer cells. Active compounds range from being 
small, such as xenocoumacins (8), xenortides (9), xenorhabdins (10) and indole derivatives 
(11), to larger, more complex compounds such as xenoamicins (12), bicornutin (13) and PAX 
peptides (14). Some compounds are cyclic, e.g. taxlllaids (15), xenobactin (16) and szentiamide 
(17), while others are linear, e.g. rhabdopeptides (18) and cabanillasin (19). Thus far, the only 
bacteriocins characterized for the genus, xenocin and xenorhabdicin, were from Xenorhabdus 
nematophila (20, 21) and Xenorhabdus bovienii (22). Bacteriocins have also been isolated from 
Xenorhabdus beddingii, but they have not been characterized (23). Antimicrobial compounds 
produced by Xenorhabdus bacteria are listed along with their producer species in Table 1.  
 
This study reports on the isolation, purification and identification of antimicrobial compounds 
produced by Xenorhabdus khoisanae SB10. This is the first report on antimicrobial compounds 
produced by this species. Furthermore, the temperature stability and activity spectrum of Sep-
Pak column partially purified antimicrobials produced by X. khoisanae SB10 was determined.  
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Table 1 Antimicrobial compounds produced by Xenorhabdus spp. 
Antimicrobial compound Producer species Source 
Depsipeptides   
Xenoamicins Xenorhabdus doucetiae and Xenorhabdus mauleonii (12) 
Taxlllaids Xenorhabdus indica (15) 
Xenematides Xenorhabdus nematophila (9) 
Xenobactin Xenorhabdus sp. strain PB30.3 (16) 
Szentiamide Xenorhabdus szentirmaii (17) 
Xenocoumacins X. nematophila, Xenorhabdus miraniensis and  
Xenorhabdus kozodoii 
(8, 24) 
Fabclavines X. szentirmaii and Xenorhabdus budapestensis  (25) 
Xenortides X. nematophila (9) 
Rabdopeptides X. nematophila and Xenorhabdus cabanillasii (18) 
Bicornitun Xenorhabdus budapestensis (13) 
PAX peptides X. nematophila (14) 
Cabanillasin and Nemaucin X. cabanillasii (19) 
Xenorhabdins Xenorhabdus bovienii and Xenorhabdus miraniensis (10, 26) 
Xenorxides X. bovienii (27) 
Indole containing compounds   
Indole derivatives X. nematophila and X. bovienii (11, 28) 
Nematophin X. nematophila (29) 
Benzylideneacetone X. nematophila (30) 
Rhabducin X. nematophila (31) 
Bacteriocins     
Xenocin X. nematophila (20) 
Xenorhabdicin X. nematophila and X. bovienii (21, 22) 
 
Materials and methods 
 
Bacterial strains, growth media and growth conditions. Xenorhabdus khoisanae SB10 was 
maintained on NBTA, consisting of nutrient agar supplemented with bromothymol blue 
(0.025%, w/v) and triphenyltetrazoliumchloride (TTC, 0.004%, w/v), and incubated at 30 °C. 
The bacteria, yeasts and filamentous fungi used as targets in the testing for antimicrobial 
activity, and the culturing conditions used for each, are listed in Table 2. All growth media 
used in this study were obtained from Biolab Diagnostics (Gauteng, South Africa). 
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Table 2 Target microorganisms and culturing conditions. 
Microorganism Mediab Temp 
(°C) 
Source 
Gram-positive bacteria    
Enterococcus sp.  BHI 37 DMSUc 
Listeria monocytogenes EDGE BHI 37 Caliper Life sciences, Hopkinton, 
MA, USA  
Staphylococcus epidermidis BHI 37 DMSU 
Staphylococcus aureus 30 (MRSAa), 
31 (MRSA) 
BHI 37 Caliper Life sciences, Hopkinton, 
MA, USA 
Streptomyces scabiei YPD 30 DPPSUd 
Bacillus subtilis subsp. subtilis 
BD170 
BHI 37 DMSU 
Gram-negative bacteria    
Escherichia coli Xen 14 BHI 37 DMSU 
Salmonella typhimurium Xen 26 BHI 37 DMSU 
Pseudomonas aeruginosa Xen 5 BHI 37 DMSU 
Pectobacterium carotovorum YPD 30 DPPSU  
Agrobacterium vitis Ag119 YPD 30 DPPSU  
Agrobacterium tumefaciens Ag120 YPD 30 DPPSU  
Yeasts    
Cryptococcus neoformans var. grubii 
CAB 843 
PD 37 DMSU  
Candida albicans CAB 392 PD 37 DMSU 
Filamentous fungi    
Botrytis cinerea PD 26 DVOSUe 
Fusarium oxysporum f. sp. cubensis PD 26 DPPSU 
aMRSA: Methicillin resistant Staphylococcus aureus. 
bGrowth media; PD: potato dextrose, BHI: brain heart infusion, YPD: yeast peptone dextrose 
cDMSU: Culture collection of the Department Microbiology, Stellenbosch University. 
dDPPSU: Culture collection of Department Plant Pathology, Stellenbosch University. 
eDVOSU: Culture collection of Department Viticulture and Oenology, Stellenbosch 
University. 
Stellenbosch University  https://scholar.sun.ac.za
 
 
85 
 
Isolation of antimicrobial compounds. See Fig. 1 for flow chart of antimicrobial isolation 
and purification. XAD-16 beads were activated by treating with 80% isopropanol containing 
0.1% trifluoroacetic acid (TFA) (v/v). Activated XAD-16 beads were added to tryptic soy broth 
(TSB) and placed on an orbital shaker at 100 rpm for 30 min, at 4 °C. The beads were removed 
and the medium autoclaved. Xenorhabdus khoisanae SB10 was inoculated into 5 ml TSB and 
incubated at 26 °C for 24 h on a rotating wheel.  After incubation the culture was added to 5 g 
activated XAD-16 beads, spread-plated onto XAD-16-treated TSB agar, using petri dishes with 
a diameter of 135 mm, and incubated at 26 °C for 96 h. After incubation, beads were collected 
from agar and washed with double distilled water (ddH2O) to remove bacterial cells. Double 
distilled water was removed from beads by vacuum suction and 150 ml 30% (v/v) ethanol 
added to beads collected from four petri dishes.  The suspension with beads was incubated at 
4 °C for 15 min on an orbital shaker (100 rpm). Ethanol was removed by vacuum suction. The 
beads were washed with ddH2O and hydrophobic compounds eluted from the beads using 
70% (v/v) isopropanol containing 0.1% (v/v) TFA (isopropanol-TFA). The eluent was filtered 
through a 0.45 µM cellulose nitrate filter and the isopropanol removed by a rotary evaporator 
(RotaVapor® R-114, Büchi), connected to a waterbath (Waterbath B-480, Büchi). 
 
Purification of antimicrobial compounds. The eluent was subjected to reverse phase 
chromatography on a Sep-Pak C18 column. The column was washed with ddH2O and 
hydrophobic compounds eluted by using a stepwise isopropanol-TFA gradient ranging from 
10% to 70% isopropanol (with 10% increments). The antimicrobial activity of fractions was 
tested using an agar-well diffusion assay. In short, BHI agar (1.0%, w/v), was seeded with a 
dense 12-h-old culture of B. subtilis subsp. subtilis BD170 (1.0%, v/v). Wells were made into 
the agar and 20 µl of each fraction dispensed into a well. A clear zone surrounding the well 
indicated activity. Isopropanol was removed from active fractions (SPC active fractions) by 
rotary evaporation, as described previously. Samples were lyophilized and resuspended in 50% 
acetonitrile. Two separate methods were used for further purification of the antimicrobial 
compounds. 
 
Method A. The SPC active fractions were loaded onto a HiScale column (16 × 100 mm) 
packed with 15 RPC resin (GE healthcare, South Africa) fitted to fast protein liquid 
chromatography (FPLC, ÄKTA purifier, GE healthcare, South Africa). Fractions were eluted 
by a linear gradient of 10% to 55% B1 in 30 min, at a flow rate of 2.5 ml/min (A: MilliQ water 
containing 0.1% TFA, v/v, and B1: Acetonitrile containing 0.1% TFA, v/v). Absorbance 
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readings were recorded at 254 nm. Fractions were tested for antimicrobial activity using the 
agar-well diffusion assay as described previously. 
 
The active fraction from the ÄKTA purifier (FPLC active fraction) was lyophilized, 
resuspended in 50% (v/v) acetonitrile, and loaded onto a Discovery BIO Wide Pore C18 HPLC 
column (10 μm, 250 × 10 mm; Sigma-Aldrich) and eluted by using a linear gradient (25% to 
45%) of eluent B1 over 28 min. The flow rate was 2 ml/min. Absorbance readings were 
recorded at 254 nm. A Surveyor plus HPLC (Thermo Fisher Scientific, Waltham, 
Massachusetts, USA) was used. Peaks were collected and activity tested as described 
previously. Active fractions (HPLC-A) were freeze dried and stored at -20 °C, until further use. 
 
Method B. A separate batch of hydrophobic compounds obtained from isolation with XAD-
16 beads was separated by using a Sep-Pak C18 column, the isopropanol evaporated and SPC 
active fractions lyophilized as described previously. SPC active fractions were resuspended in 
50% (v/v) acetonitrile, loaded onto a Discovery BIO Wide Pore C18 HPLC column and eluted 
by a Waters Corporation non-linear, slightly convex gradient of 5 from 30% to 70% B2 over 
12.5 min, at a flow rate of 3 ml/min (A: MilliQ water containing 0.1% TFA, v/v, and B2: 90% 
Acetonitrile containing 0.01% TFA, v/v). The column was heated to 45 °C to enhance peak 
resolution. The chromatographic system consisted of two Waters 510 pumps and a Waters 440 
detector. Absorbance readings were recorded at 254 nm. Fractions were tested for antimicrobial 
activity as mentioned previously. Active fractions (HPLC-B1) were freeze dried and stored at 
-20 °C, until further use.  
 
HPLC-B1 fractions that eluted at between 7 and 9 min, excluding fractions that eluted at 7.66 
min to 7.83 min and 8.42 min to 8.58 min, were resuspended in 50% acetonitrile and loaded 
onto the same C18 HPLC column as used previously. These fractions had antimicrobial 
activity, but peak resolution was poor and therefore further purification was needed.  Peaks 
were separated by using a linear gradient of 40% to 60% B2 over 12.5 min, at a flow rate of 
3 ml/min. The column was heated to 45 °C as mentioned previously. Fractions were tested for 
antimicrobial activity as described before. Active fractions (HPLC-B2) were freeze dried and 
stored at -20 °C until further use. 
 
Stellenbosch University  https://scholar.sun.ac.za
 
 
87 
 
 
 
Figure 1 Antimicrobial isolation and purification flow chart. 
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Ultra-performance liquid chromatography (UPLC) and electrospray ionization mass 
spectrometry (ESI-MS). All active fractions from method A and B were analyzed by UPLC 
and ESI-MS. Analyses were performed at the Central Analytical Facility of Stellenbosch 
University (LCMS unit). Active peaks were analyzed by using a Waters Quadrupole Time-of-
Flight Synapt G2 mass spectrometer (Waters Corporation, Miliford, USA) coupled to an 
Acquity UPLC. Three microliters of each sample was directly injected for direct mass analysis. 
For UPLC-MS analysis, 3 µl of each sample was separated on a UPLC C18 reverse-phase 
analytical column (Acquity UPLC® HSS T3, 1.8 µm particle size, 2.1 x 150 mm, Waters 
Corporation, Dublin, Ireland), at a flow rate of 0.4 ml/min. Eluents A and B3 were 0.1% formic 
acid and 100% acetonitrile, respectively. Compounds were eluted using a linear gradient of 5% 
to 100% B3. Capillary voltage, cone voltage and source temperatures were 3 V, 15 V and 
120 °C, respectively. Masslynx software version 4.1 (Waters Corporation, Milford, USA) was 
used to analyze the data. 
 
Antimicrobial spectrum. Antimicrobial activity against bacteria and yeast (listed in Table 1) 
was determined using the agar-well diffusion assay, as described previously. SPC active 
fractions were suspended in MilliQ water, containing 0.1% (v/v) TFA to 350 mg/ml. Agar 
media, listed in Table 1, were seeded with 1.0% (v/v) actively growing cells of bacteria or 
yeast. Wells were made into the seeded agar and filled with 15 µl SPC active fractions. Plates 
were incubated for 24-48 h at the temperature listed for each strain (Table 1). The area 
surrounding a well was visually inspected for changes in bacterial or yeast growth.  
Antimicrobial activity against filamentous fungi was determined by mixing 200 µl SPC active 
fractions (350 mg/ml) with 10 ml potato dextrose agar (1% v/v), poured into sterile plates and 
allowed to solidify.  The same 350 mg/ml suspension with antimicrobial activity was used. An 
agar plug with mycelial growth, cut from a 7-day-old culture, was placed on the surface of the 
PDA with the incorporated antimicrobial suspension and incubated at 26 °C.  Mycelial growth 
was recorded after 4 days and compared to the controls. 
 
Temperature stability. SPC active fractions of 350 mg/ml were prepared in MilliQ water, 
containing 0.1% (v/v) TFA. The suspension was autoclaved for 20 min and tested for 
antimicrobial activity against B. subtilis subsp. subtilis BD170, using the agar-well diffusion 
assay as described previously. Plates were incubated at 37 °C for 24 h.  The diameter of growth 
inhibition zones was recorded and compared to controls. This was done by using the software 
program ImageJ (v. 1.48). 
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Results  
 
Isolation and partial purification of antimicrobial compounds. Strain SB10 produced 
antimicrobial compounds, however, much more activity was observed when grown on solid 
media than in liquid broth. Isolating antimicrobial compounds from solid media and treatment 
of growth media with XAD-16 beads before autoclaving led to a significant reduction in 
background during liquid chromatography. Hydrophobic compounds, isolated from XAD-16 
beads, were separated into several fractions when subjected to reverse phase Sep-Pak C18 
chromatography. Fractions that eluted between 20 and 50% isopropanol containing 0.1% TFA 
(i.e. four fractions in total - SPC active fractions) were active against B. subtilis subsp. subtilis 
BD170.  
 
Method A. SPC active fractions separated into several peaks on the 15 RPC resin (FPLC, 
ÄKTA purifier), as can be seen in Fig. 2. Fraction A1 (FPLC active fraction) eluted between 
20 and 22 min, at approximately 31-36% B1 and was active against B. subtilis subsp. subtilis 
BD170.  Further separation of this fraction by HPLC on a C18 column, with an applied gradient 
of 25 to 45% B1, yielded nine active peaks (Fig. 3). A summary of the UPLC-MS results is 
shown in Table 3. 
 
 
Figure 2 Method A, step one. Separation of SPC active fractions on 15 RPC resin by FPLC, 
with a linear gradient of 10 to 55% (v/v) acetonitrile in 0.1% (v/v) TFA. 
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According to ESI-MS, compounds 1 and 2 (from peaks AA and AB, respectively; Fig. 3) have 
monoisotopic masses of 670.41 Da (671.41 m/z, [M + H]+) and 406.22 Da (407.22 m/z [M + 
H]+), respectively. The ESI-MS analyses and MSe fragmentation patterns of the two 
compounds are shown in Figs 4 and 5. Several larger compounds with mass-to-charge ratios 
of 1052.79 m/z, 1066.81 m/z, 1070.79 m/z, 1078.80 m/z, 1080.82 m/z and 1106.84 m/z were 
revealed by ESI-MS spectra. The positive mass spectra obtained for these compounds revealed 
a repeating 128.09 m/z neutral loss, as well as a dehydration pattern (Fig. 6). Ions with a mass-
to-charge ratio of 84.08 m/z and 129.10 m/z were repeatedly observed in all these samples. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3 Method A, step two. C18 HPLC chromatogram of the fraction representing peak A1 
in Fig. 2 (FPLC active fraction).  A linear gradient from 25-45% acetonitrile containing 0.1% 
TFA was used. 
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Table 3 Method A, UPLC-MS data summary and compound identification. 
Peak  Compound/ a m/z Monoisotopic mass / 
Theoretical Mr 
Concentration in peak 
according to MS (%)c 
AA 1 671.41 670.41 93.33 
AB 2 407.22 406.22 82.96 
3 1052.79  1051.79 12.76 
AC 4a 250.22, 268.23, 
286.24 
NAb 71.12d 
5 213.57 637.72 28.87d 
AD 6 1078.80 1077.80 38.38 
4a 250.22, 268.23, 
286.24 
NA 35.70 
7 1070.79 1069.79 3.01 
AE 4a 250.22, 268.23, 
286.24 
NA 61.27 
8 270.24 269.24 11.42 
9 1066.81 1065.81 10.64 
10 790.43 789.43 8.37 
AF 
 
4a 250.22, 268.23, 
286.24 
NA 57.72 
10 790.42 789.42 15.21 
3 351.60 1051.81 7.89 
AG 11 1080.82 1079.82 83.27 
AH 
 
11 1080.82 1079.82 28.45 
12 252.23 251.23 26.52 
3 1052.79 1051.79 9.77 
13 1106.84 1105.84 6.37 
AI 3 263.95 1051.81 83.20 
a, Combination of compounds 
b, NA: Not Applicable  
c, Showing percentages above 3.0% only 
d, Based on direct injection  
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Figure 4 (A) ESI-MS analysis and (B) MSe fragmentation pattern of compound 1, 671.41 m/z. 
Masses indicated are singly charged species [M + H]+. 
A 
B 
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Figure 5 (A) ESI-MS analysis and (B) MSe fragmentation pattern of compound 2, 407.22 m/z. 
Masses indicated are singly charged species [M + H]+. 
A 
B 
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Figure 6 ESI-MS analysis of compound 3 (1052.79 m/z), as representative of compounds 6, 7, 
9, 11 and 13 with similar characteristics. MaxEnt3 was used to generate this positive mass 
spectrum. Arrows, asterisks and circles indicate the repeating 128.09 m/z neutral loss pattern, 
dehydration and, 84.08 m/z and 129.10 m/z ions, respectively. Masses indicated are singly 
charged species [M + H]+. 
 
Method B. During the second purification method, a two-step HPLC protocol was used instead 
of using FPLC followed by HPLC. The first step consisted of using a non-linear gradient at a 
column temperature of 45 °C. The non-linear gradient condensed compounds that eluted non-
specifically to elute at a more specific time, as shown in Fig. 7, compared to the entire gradient 
as in method A (Fig. 3). Altering of the gradient enabled purification of peaks B2 to B9. The 
heated column enhanced peak resolution. Antimicrobial activity was observed for fraction B1, 
and peaks B2, B3, B4, B5, B8 and B9. Fraction B1 (a combination of the area before peak B2, 
between peaks B2 and B3 and between peaks B3 and B4), was used during the second HPLC 
purification process as peaks could not be separated sufficiently during the first HPLC step. 
Peaks were sufficiently separated during this protocol (Fig. 8). Antimicrobial activity was 
observed for all peaks, excluding peak BI. See Table 4 for summary of UPLC-MS data. 
 
 
 
∆128.09 ∆128.09 ∆128.09 ∆128.09 ∆128.09 ∆128.09 * * * * **
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Figure 7 Method B, step one. HPLC Chromatogram of sample SB10, run on a non-linear, 
slightly convex Waters Corporation 5 gradient of 30-70% B (B2: 90% Acetonitrile containing 
0.1% TFA). Fraction B1 was collected as the background between peaks B2, B3 and B4.  
 
 
 
Figure 8 Method B, step two. HPLC Chromatogram of sample SB10, fraction B1 (excluding 
peaks B2 and B3) from the first HPLC step of method B, run on a linear gradient of 40-60% B 
(B2: 90% Acetonitrile containing 0.1% TFA).  
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Overall, the same dominant compounds were detected in the ESI-MS data of samples from 
method B, as were detected in samples from method A. These include the larger compounds, 
3 (1051.81 Da) and 11 (1079.84 Da), the combination of compounds with mass-to-charge ratios 
of 268.23 m/z, 286.24 m/z and 250.22 m/z, and compounds 1 (671.41 m/z) and 2 (407.22 m/z). 
Compound 21 from peak B9 showed significant activity against B. subtilis subsp. subtilis 
BD170 and was not detected in samples from method A. This compound with a mass-to-charge 
ratio of 285.07 m/z, had a significant bright yellow color and an UV absorbance at 392.12 nm 
(Fig. 9). The fragmentation profile (Fig. 10) reveals a daughter ion of 186.99 m/z. Peaks B2 
(consisting of compounds 434.27 m/z and 341.15 m/z) and BD (259.17 m/z) had activity. See 
Fig. 11, and supplementary Figs S1 and S2, for ESI-MS analyses and MSe fragmentation 
patterns of compounds 259.17 m/z, 434.27 m/z and 341.15 m/z, respectively. 
 
 
Figure 9 Diode array of compound 21, 285.07 m/z, indicating absorbance at 329.12 nm. 
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Figure 10 (A) ESI-MS analysis and (B) MSe fragmentation profile of compound 21, indicating 
the parent and daughter ions, 258.07 m/z and 186.99 m/z, respectively.  Masses indicated are 
singly charged species [M + H]+. 
 
 
 
A 
B 
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Figure 11 (A) ESI-MS analysis and (B) MSe fragmentation profile of compound 24, 
259.17 m/z. Masses indicated are singly charged species [M + H]+. 
 
A 
B 
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Table 4 Method B, UPLC-MS data summary and compound identification. 
Peak Compound/ a m/z Monoisotopic mass 
/ Theoretical Mr 
Concentration in peak 
according to MS (%)c 
B2 14 434.27 433.27 70.76 
15 341.15 340.15 24.05 
1 671.41 670.41 Trace amounts 
B3 2 407.22 406.22 53.83 
10 790.43 789.43 37.86 
B4 4a 250.22, 268.23, 
286.24 
NAb 26.49 
16 266.21 265.21 21.49 
12 252.23 251.23 17.85 
17 751.41 750.41 15.47 
8 270.24 269.24 11.98 
B5 12 252.23 251.23 46.81 
4a 250.22, 268.23, 
286.24 
NAb 25.04 
B8 20 307.06 306.06 ND 
B9 21 285.07 284.07 78.75 
4 250.22, 268.23, 
286.24 
NAb 5.85 
BA 3 351.60, 526.91 1051.81 ND 
BB 3 351.60, 526.91 1051.81 61.85 
23 1124.64 1123.64 12.44 
15 341.15 340.15 10.61 
BC 14 434.27 433.27 68.76 
15 341.15 340.15 22.90 
3 351.68, 527.09 1051.81 8.34 
BD 24 259.17 258.17 91.41 
BE 2 407.22 406.22 71.32 
11 360.94, 540.92, 
1080.82  
1079.84 9.97 
 
BF 10 790.43 789.43 45.28 
4a 250.22, 268.23, 
286.24 
NA 24.83 
BG 10 790.43 789.43 29.11 
17 751.41 750.41 27.58 
11 360.94, 540.92 1079.84 24.78 
BH 4a 250.22, 268.23, 
286.24 
NA 81.50 
11 360.94, 540.92 1079.84 9.03 
a, Combination of compounds 
b, NA: Not Applicable  
c, Showing percentages above 3.0% only 
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Antimicrobial spectrum and temperature stability. SPC active fractions from strain 
X. khoisanae SB10, were tested against filamentous fungi, yeasts and Gram-positive and 
Gram-negative bacteria. Growth of all target microorganisms was inhibited. Furthermore, 
treating SPC active fractions at 121 °C, for 20 min, did not have a significant effect on activity 
against B. subtilis subsp. subtilis BD170. 
 
Discussion 
 
Xenorhabdus bacteria are known to produce various antimicrobial compounds, but it is 
however, a highly neglected antimicrobial source that has not been exploited to its full 
potential. Therefore, antimicrobial isolation, purification, identification and characterization 
have not been done for all species belonging to this genus. This study isolated antimicrobial 
compounds from the species, X. khoisanae for the first time. Due to the Xenorhabdus-
Steinernema-insect host tripartite relationship, it was not surprizing to discover the production 
of various antimicrobial compounds by this species. Two different methods were used for 
purification of these compounds, which led to similar, but not identical purified antimicrobial 
compounds.  
 
Method A. Compound 1 (671.41 m/z) was identified as a novel antimicrobial compound. The 
MSe fragmentation pattern of this compound revealed a daughter ion with a mass-to-charge 
ratio of 473.28 m/z (Fig. 4). Further research needs be done to elucidate the structure. 
Compound 2, with a monoisotopic mass of 406.22 Da, was identified in the ESI-MS spectrum 
obtained for peak AB. Two daughter ions with mass-to-charge ratios of 158.08 m/z and 
250.15 m/z were revealed by the fragmentation pattern (Fig. 5). Two additional species, 
176.07 m/z and 232.13 m/z, were observed and determined to be the hydration and dehydration 
products of the two daughter ions, 158.08 m/z and 250.15 m/z, respectively. Compound 2 was 
identified as xenocoumacin 2 based on the characteristic fragmentation pattern. Fragment 
250.15 m/z represents the benzopyran-1-one fragment, while fragment 158.08 m/z represents 
the remaining fragment with the pyrrolidine as R group (24) (Fig. 12). This identification was 
supported by antiSMASH (32) results of 100% similarity between the genome of strain SB10 
and the xenocoumacin biosynthetic gene cluster. 
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Figure 12 MSe fragmentation pattern and chemical structure of compound 2, xenocoumacin 2, 
indicating corresponding fragments.  Masses indicated are singly charged species [M + H]+.  
 
A combination of fragments (combination 4), including the two daughter ions of 
xenocoumacin 2, was detected in peaks AC, AD, AE and AF. This combination consisted of 
singly charged species [M + H]+ with mass-to-charge ratios of 250.22 m/z, 268.23 m/z 
(hydration product of 250.22 m/z), 286.24 m/z (hydration product of 268.23 m/z) and 
158.09 m/z (See supplementary Fig. S3 for ESI-MS analysis and MSe fragmentation profile). 
The benzopyran-1-one fragment of xenocoumacins 2 may be hydrated to produce 
xenocoumacin 6 (24) (Fig. 13). This fragment will therefore have a mass-to-charge ratio of 
268.22 m/z, which was observed in this sample. However, no xenocoumacin parent ions were 
observed when MS data of these peaks were studied, suggesting that these compounds were 
degraded or isolated mid-production. Therefore, it is suggested that isolate SB10 also produces 
xenocoumacin 6, the hydration product of xenocoumacin 2. The hydration product of 
268.23 m/z (286.24 m/z) may indicate the production of another xenocoumacin derivative, 
where xenocoumacin 6 is further hydrated.  
Xenocoumacin 2 
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Figure 13 Hydration of xenocoumacin 2 to xenocoumacin 6. 
 
The larger compounds with mass-to-charge ratios of 1052.79 m/z, 1066.81 m/z, 1070.79 m/z, 
1078.80 m/z, 1080.82 m/z and 1106.84 m/z revealed repeated dehydration and neutral losses of 
128.09 m/z, indicative of lysine residues. Additionally, two ions, 84.08 m/z and 129.10 m/z, 
were detected in the ESI-MS spectrum, which are known as lysine associated ions. These traits 
were recognized as characteristics of lysine-rich cyclic lipopeptides, called PAX (peptide-
antimicrobial-Xenorhabdus) peptides. These compounds were first characterized by Gaulteri 
et al. (14) and to date a total of 13 PAX peptides have been reported (33).  The peptides 
identified here (compounds 3, 6, 11, 9 and 13), correspond directly with the mass-to-charge 
ratios of known PAX peptides; PAX 1 (1052.79 m/z), PAX 6 (1078.78 m/z), PAX 2 
(1080.82 m/z), PAX 3 (1066.81 m/z) and PAX 9 (1106.82 m/z). However, a PAX peptide with 
a monoisotopic mass of 1069.79 Da, which was identified from peak AD, has not been 
reported. This compound exhibits the previously discussed characteristics of PAX peptides 
(Fig. S4). This is therefore a novel PAX peptide, PAX 14. PAX peptides have only been 
isolated from Xenorhabdus nematophila, therefore, this is the first report of PAX peptides from 
another species. 
 
Method B. Four active compounds detected in samples from method B were not detected in 
samples from method A.  These include compounds 14 (434.27 m/z), 15 (341.15 m/z), 21 
(285.07 m/z) and 24 (259.17 m/z) (Figs S1, S2, 10 and 11). Compounds 14 and 15 need to be 
purified to determine the active compound, as the active fraction tested in this study contained 
both these compounds.   
 
Throughout the isolation process it was noted that the sample from peak B9 was bright yellow, 
which suggested this sample contains xenorhabdins, as these compounds have been reported 
to be bright yellow (10). This was confirmed when ESI-MS and MSe fragmentation data of 
compound 21 was analyzed. Compound 21 has a parent ion with a mass-to-charge ratio of 
Xenocoumacin 2 Xenocoumacin 6 
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285.07 m/z and a daughter ion of 186.99 m/z. This corresponds directly with characteristics of 
xenorhabdin 4, and compound 21 was identified accordingly (10).  
 
Comparison of purification methods. Compounds that were detected in the ESI-MS data of 
method A and B include members of the PAX family (PAX 1, 1051 Da and PAX 2, 1079 Da), 
xenocoumacin 2, fragments of xenocoumacin 6 and compound 1 (671.41 m/z). Method A 
proved to produce more pure compounds when comparing concentrations of PAX peptides 
(PAX 1 and 2) and xenocoumacin 2 to that of method B (Table 5). Fragments of xenocoumacin 
6 were however, more pure when using method B. Method A, therefore, proved to be the better 
method for purification when taking all compounds into consideration. However, xenorhabdin 
4 (compound 21, peak B9), compound 14, 15 and 21 were detected only in samples purified 
using method B. This might be due to the purification process selecting for purification of these 
compounds, more than the first method. This is similar for compound 1, which was detected 
only in the sample from method A. This phenomenon is however, likely the cause of using two 
separate isolation batches for testing of the two purification methods. Direct comparison of 
these two methods should be done with the same isolation batch to ensure consistency and 
reliability of results.  
  
Table 5 Comparison of active compound concentrations between methods A and B. 
Compound Monoisotopic 
mass (Da) 
Method A Method B 
Peak Concentration in 
peak (%) 
Peak Concentration in 
peak (%) 
Xenocoumacin 2 406.22 AB 82.96 B3 53.83 
Xenocoumacin 6 
fragments 
250.22, 
268.23, 
286.24a 
AC 71.12 BH 81.50 
PAX peptide 1 1051.79 AI 83.20 BB 61.85 
PAX peptide 2  1079.82 AG 83.27 BG 24.78 
a, Mass-to-charge ratios 
 
Antimicrobial spectrum and temperature stability. SPC active fractions from strain 
X. khoisanae SB10 inhibited growth of all target strains tested. Antimicrobial purification from 
X. khoisanae SB10, revealed the bioactive compounds produced by this strain as PAX peptides, 
xenocoumacins, xenorhabdins and three to four (671.41 m/z, 259.17m/z and 434.27 m/z and/or 
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341.15 m/z) unidentified compounds. Xenocoumacin 2 has been shown to be active against 
both Gram-negative and Gram-positive bacteria (8). PAX peptides 1-5 showed weak activity 
against bacteria, but were active against filamentous fungi and yeasts with MIC (minimal 
inhibitory concentration) values as low as 1.56 µg/ml against Fusarium oxysporum (14). 
Lastly, xenorhabdin 4 has been shown to be active against Micrococcus luteus (10). These 
compounds, therefore, all play a role in the overall bioactivity exhibited by these bacteria. It is 
proposed that these compounds do not merely have an additive effect, but synergistic as well. 
Furthermore, the stability of these compounds at 121 °C, for 20 min, is likely due to the cyclic 
nature of these compounds. Stability of antimicrobial compounds is very important in industry 
as this increases the ease of working with and storage of compounds. This is therefore a highly 
desired characteristic of these compounds. 
 
Conclusion 
 
SPC active fractions produced by X. khoisanae SB10, were shown to have broad-spectrum 
activity and stability at 121 °C, for 20 min. Purification of the antimicrobial compounds 
produced by strain SB10 revealed the production of various compounds including PAX 
peptides, xenocoumacins, xenorhabdins, as well as, unidentified compounds with 
monoisotopic masses, 670.41 Da, 258.17 Da, 433.27 Da and 340.15 Da. These compounds 
therefore, all play a role in the overall antimicrobial activity of strain SB10. This study reports 
on the production of PAX peptides, xenocoumacins and xenorhabdins by X. khoisanae for the 
first time. Furthermore, three to four novel antimicrobial compounds have been discovered. 
Future studies may be done on the characterization and structure elucidation of these unknown 
compounds as it is not covered by the scope of this study. 
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Supplementary material 
 
 
 
Figure S1 (A) ESI-MS analysis and (B) MSe fragmentation profile of compound 14, 
434.27 m/z. Masses indicated are singly charged species [M + H]+.  
B 
A 
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Figure S2 (A) ESI-MS analysis and (B) MSe fragmentation profile of compound 15, 
341.15 m/z. Masses indicated are singly charged species [M + H]+. 
 
 
  
B 
A 
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Figure S3 (A) ESI-MS analysis and (B) MSe fragmentation profile of combination 4 revealing 
xenocoumacin 2 and xenocoumacin 6 fragments. Masses indicated are singly charged species 
[M + H]+. 
B 
A 
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Figure S4 ESI-MS analysis of compound 7 (PAX 14), revealing the typical repeating neutral 
loss of 128.09 m/z fragments and dehydration of PAX peptides, as well as, lysine related ions, 
84.08 m/z and 129.10 m/z. Masses indicated are singly charged species [M + H]+. 
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General Discussion  
 
Four Xenorhabdus strains were isolated from four different Steinernema species: 
Steinernema sacchari SB10T Nthenga, Knoetze, Berry, Tiedt and Malan; 
Steinernema jeffreyense J194T Malan, Knoetze and Tiedt; Steinernema nguyeni F2T Malan, 
Knoetze and Tiedt; and Steinernema litchii WS9T Steyn, Knoetze, Tiedt and Malan. 
Xenorhabdus isolates were named to correspond to their nematode source, Xenorhabdus 
isolates SB10, J194, F2 and WS9, respectively. Biochemical characteristics were determined, 
only to identify differences between strains, and a molecular approach was taken for species 
identification.  
 
A 98-99% similarity was obtained for 16S rDNA, gltX and dnaN sequences between isolate F2 
and Xenorhabdus bovienii T228T. Translated BLAST analysis supported this finding and 
isolate F2 was identified as a strain belonging to the species X. bovienii. The association of 
X. bovienii with S. nguyeni was expected as S. nguyeni belongs to the Feltiae-clade (1) and 
X. bovienii is associated with eight other Steinernema species belonging to this clade. 
 
Sequences obtained for housekeeping genes gltx, recA, dnaN, gyrB and infB, and 16S rDNA 
(including upstream and downstream regulatory elements) of isolates J194 and SB10 showed 
96-99% similarity to corresponding gene sequences of Xenorhabdus khoisanae SF87T. 
Identification of isolates J194 and SB10 as strains of X. khoisanae was supported by protein 
similarity searches.  Similar to the X. bovienii-S. nguyeni association, the X. khoisanae-
S. jeffreyense association was expected, as X. khoisanae has also been isolated from 
Steinernema khoisanae which belongs to the same clade (Glaseri) as S. jeffreyense (2, 3). 
However, the X. khoisanae-S. sacchari association was not anticipated. Steinernema sacchari 
belongs to the Cameroonense-clade (4), which is closely related to the Feltiae-, and not 
Glaseri, -clade, as would be expected for a nematode associated with X. khoisanae. It was, 
therefore concluded that X. khoisanae has the ability to switch between nematodes belonging 
to distantly related clades (Glaseri and Cameroonense clades). 
 
Sequences obtained for the 16S rDNA and housekeeping genes of isolate WS9 had similarities 
of 98-99% to X. griffiniae ID10T, excluding the recA gene which had a 96% similarity to 
X. ehlersii DSM16337T. Protein-coding genes were most similar to those of X. griffiniae ID10T, 
excluding the recA and infB genes, which were more similar to those of X. ehlersii DSM16337T 
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and Xenorhabdus sp. TZ01, respectively. This suggests that isolate WS9 is closely related to 
X. griffiniae and to a lesser extent to X. ehlersii and Xenorhabdus sp. TZ01. Isolate WS9 was 
therefore classified as a member of the X. griffiniae species. It was therefore proven that 
X. griffiniae WS9 is associated with S. litchii WS9T from the Karii-clade (5). 
Xenorhabdus griffiniae has previously been isolated from Steinernema hermaphroditum 
Stock, Griffin and Chaerani, a member of the Longicaudum-clade and an uncharacterized 
Steinernema sp. strain BMMCB (6). Therefore, X. griffiniae has the ability, similar to 
X. khoisanae, to switch between nematodes belonging to different clades.     
 
Antimicrobials isolated from strain SB10 were purified using two methods and subjected to 
ESI-MS coupled to UPLC. Method A revealed eight compounds of interest, including a novel 
antimicrobial with a monoisotopic mass of 670.41 Da (671,41 m/z, [M + H]+). This compound 
had significant activity against B. subtillis subsp. subtillis BD170.  
 
A second compound with a mass-to-charge ratio of 407.22 m/z, was identified as 
xenocoumacin 2, based on the daughter ions revealed by MSe fragmentation. This 
identification was supported by antiSMASH results indicating strain SB10 to contain the 
xenocoumacin biosynthetic gene cluster. A combination of fragments 250.22 m/z, 268.23 m/z 
and 158.09 m/z were detected in several peaks. These are suggested to be fragments of both 
xenocoumacin 2 and 6. Since the parent ion was not detected in the sample, isolation of 
antimicrobials likely occurred mid-biosynthesis or, alternatively, the compounds had been 
degraded. An additional fragment was detected as the hydration product of 268.23 m/z, 
suggesting xenocoumacin 6 to be further hydrated to produce a xenocoumacin 6 derivative. 
 
The remaining six compounds detected during method A had mass-to-charge ratios of 
1052.79 m/z, 1066.81 m/z, 1070.79 m/z, 1078.80 m/z, 1080.82 m/z and 1106.84 m/z. These 
compounds revealed typical characteristics of lysine-rich cyclolipopeptides, called PAX 
(peptide-antimicrobial-Xenorhabdus) peptides (7, 8). These characteristics, as well as 
corresponding monoisotopic masses, led to the identification of these compounds as PAX 
peptides 1, 2, 3, 6 and 9. An additional, novel, PAX peptide, PAX 14 (1069.79 Da), was 
identified in this study.  
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Compounds with activity, from method B only, are compounds 434.27 m/z, 341.15 m/z, 
259.17 m/z and 285.07 m/z. The sample containing novel compounds 434.27 m/z and 
341.15 m/z showed significant activity. The source of this activity can be either one of these 
compounds or both. The compound, 285.07 m/z, was identified as xenorhabdin 4, based on the 
MS spectrum and fragmentation profile obtained, as well as the bright yellow color of the 
sample.  
 
The same predominant compounds detected in samples from method A were also detected in 
samples from method B. These include a novel antimicrobial compound (671.41 m/z), 
xenocoumacin 2, fragments of xenocoumacin 6 and PAX peptides (PAX peptides 1 and 2). 
Comparison of concentrations obtained for each compound revealed method A to be the better 
method for purification, when using two different antimicrobial isolation batches. However, 
the same antimicrobial isolation batch needs to be used to compare the two methods directly. 
The specific purification method also depends on the specific compound desired to be purified.  
 
Broad-spectrum activity of the SPC active fractions from isolate SB10 was supported by the 
previously reported activity spectrum of PAX peptides, xenocoumacins and xenorhabdins. 
These compounds all play a part in the overall activity of strain SB10 and are suggested to 
work synergistically.  
 
Conclusion  
 
Xenorhabdus bacteria are a neglected and underestimated source of bioactive compounds. In 
the current day and age, antibiotic resistance has become an immense crisis. The discovery of 
novel antimicrobial compounds is therefore of the essence, as they may be used to treat 
infections caused by antibiotic resistant strains. The time has come to investigate 
unconventional antimicrobial sources, such as Xenorhabdus, as this might hold the key to 
survival of humankind in the 21st century. 
 
During this study, four novel Xenorhabdus-Steinernema associations were discovered, 
including proof that X. khoisanae and X. griffiniae have the ability to switch between different 
nematode clades. Purification of antimicrobial compounds produced by strain SB10 revealed 
the production of known Xenorhabdus compounds, including PAX peptides, xenocoumacins 
and xenorhabdins. Three to four novel antimicrobial compounds were identified with mass-to-
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charge ratios of 671.41 m/z, 259.17 m/z, 434.27 m/z and/or 341.15 m/z. The latter two 
compounds were not sufficiently purified as the active sample contained both compounds. 
These compounds need to be further purified to determine which compound is the source of 
activity.  
 
Future studies may characterize the three novel compounds found in this study. This 
characterization includes determining the activity spectrum, cytotoxicity against cancerous 
cells and insect larvae, protease-, storage- and temperature-stability, and chemical structure. 
Structure elucidation might be done by NMR. Furthermore, the synergistic effect of all 
bioactive compounds identified during this study may be determined. 
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